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Protein S-palmitoylation plays a crucial role in many biological systems. S-palmitoylation 
involves the post-translational attachment of palmitate to a cysteine residue through a 
reversible thioester linkage. S-Palmitoylation is used to modify both integral and membrane 
proteins, many of which are involved in intracellular trafficking, membrane localization, and 
signal transduction pathways. Intracellular palmitoylation is mediated by a family of protein 
acyltransferases (PATs). PAT mutations are associated with neurological diseases and cancer 
progression. Proteins in the PAT family are defined by the presence of a 51-amino acid cysteine-
rich domain (CRD), which contains a highly conserved aspartate-histidine-histidine-cysteine 
(DHHC) motif. The structure and function of DHHC proteins are still under investigation due to 
the difficulty in purifying eukaryotic multi-pass transmembrane proteins. 
In the model eukaryotic organism Dictyostelium discoideum, fourteen DHHC proteins 
have been discovered, labeled PAZ1-14. Previous work has investigated the localization of these 
proteins during growth and differentiation, with attention paid towards their effect on 




investigation as cells transformed with a knockout PAZ5 presented a unique malformed 
phenotype in the fruiting body stage of the D. discoideum lifecycle. The fruiting body would 
collapse as fewer cells differentiated into stalk cells; the cell lines would return to normal 
functioning after rescue with the wildtype. It was also previously shown that mutations to the 
DHHC motif of PAZ5 induced the same malformed phenotype as the knockout, indicating a 
crucial role for PAZ5 in D. discoideum development. 
Using site-directed mutagenesis, seventeen independent mutations to PAZ5 were 
created, both in the DHHC-CRD and other conserved motifs. These were ligated into a 
fluorescent-tagged extrachromosomal expression plasmid (pTX-GFP) and transformed into D. 
discoideum. They were analyzed for fluorescent localization and the previously seen fruiting 
body malformations. Unforeseen low transformation efficiency prevented the full use of all 
seventeen mutants. The mutants that were able to be analyzed produced a phenotype 
dissimilar to both the wildtype and knockout strains; moreover, fluorescent localization of PAZ5 
was unable to be discerned. It was determined that the plasmid experienced a loss of function, 
though this was not apparent until after the results were collected. Consequently, it is unknown 
to what extent the observations are experimentally valid. The work can be salvaged by re-
ligating the mutant PAZ5 proteins into a new fluorescent expression plasmid. Further 





I want to thank my committee, professors Julie Gosse and Joshua Kelley, for their care in 
shepherding my research throughout this study. I am very grateful for their time and energy 
these past few years. 
Thanks to Bethany Bodwell and Joel Amburg, past students of the Gundersen lab, for 
their work in starting this project and providing the foundations for this study. Thanks also to 
my sister, Serene, for drawing her drawings in this thesis.  
I would sincerely like to thank my advisor, Dr. Robert E. Gundersen, for being the best 
mentor that I could possibly ask for. Dr. Gundersen will forever be the person that springs to 
mind when I think of what a good scientist should be. I cannot think of a single person that has 
helped nurture my interest in science more than he has these past three years. Dr. Gundersen 
taught me practically every technique that I used in this study and was there for every question 
I had, no matter how silly or unrelated they were. He would always leave his work to personally 
help if an experiment went wrong and was still willing to help improve my technique. I am 




TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ................................................................................................................... iv 
LIST OF TABLES .............................................................................................................................. viii 
LIST OF FIGURES .............................................................................................................................. xi  
CHAPTER 1. INTRODUCTION ........................................................................................................... 1 
1.1. Dictyostelium discoideum .............................................................................................. 3 
1.1.1. History of Research into D. discoideum ............................................................ 5 
1.1.2. Phylogeny and Genomics of D. discoideum ...................................................... 7 
1.1.3. Developmental Lifecycle of D. discoideum ..................................................... 10 
1.2. G Protein Signaling ....................................................................................................... 17 
1.3. Lipid Modifications ....................................................................................................... 20 
1.4. S-Palmitoylation and the DHHC Domain ..................................................................... 24 
1.5. The PAZ5 Protein/pazE Gene ....................................................................................... 31 
1.6. Rationale ...................................................................................................................... 32 
CHAPTER 2. MATERIALS AND METHODS ...................................................................................... 37 
2.1. Cell Culture ................................................................................................................... 37 
2.2. Polymerase Chain Reactions ........................................................................................ 37 
2.3. Restriction Enzyme Digestion ...................................................................................... 43 
2.4. Gel Electrophoresis ...................................................................................................... 45 
2.5. High-Efficiency Transformation and Cloning into E. coli ............................................. 45 
2.6. Ligation and Verification of Fusion Protein Expression Vectors .................................. 47 
2.7. Sequencing PAZ5 for Mutation and KpnI Linker Cassette ........................................... 49 
 
vi 
2.8. Transformation of Expression Vector into D. discoideum via Electroporation ........... 51 
2.9. Storing D. discoideum Cell Lines .................................................................................. 52 
2.10. Photography of D. discoideum Development ............................................................ 53 
2.11. Confocal Imaging of Fluorescent D. discoideum Cells ............................................... 54 
2.12. Statistical Analysis of Mutant Phenotypes versus Wild-Type .................................... 55 
2.13. Rescue of Knockout.................................................................................................... 56 
2.14. Development on Bacterial Lawn ................................................................................ 57 
CHAPTER 3. RESULTS ..................................................................................................................... 58 
3.1. Creation of PAZ5-KO and PAZ5 Mutant Cell Lines ....................................................... 58 
3.2. Creation of PAZ5/pTX-GFP Fusion Expression Vector ................................................. 63 
3.3. Localization of Fluorescence for GFP-Tagged Cells ..................................................... 67 
3.4. Characterizing the Developmental Phenotypes of D. discoideum Strains .................. 74 
CHAPTER 4. DISCUSSION ............................................................................................................... 92 
4.1. Low Transformation Efficiency of PAZ5/pTX-GFP into D. discoideum ......................... 92 
4.2. Absence of Fluorescent Signal for PAZ5/pTX-GFP Strains ........................................... 94 
4.3. Characterization of Knockout and Mutant Phenotypes .............................................. 97 
4.4. Potential Remedies for the Malfunctioning PAZ5/pTX-GFP Plasmid ........................ 103 
4.5. Conclusions and Future Directions ............................................................................ 105 
REFERENCES ................................................................................................................................ 107 
APPENDIX A. PAZ5 AND PTX-GFP RESTRICTION SITES AND SEQUENCES ................................... 122 
APPENDIX B. PAZ5 MUTANT SEQUENCE ALIGNMENTS .............................................................. 135 




APPENDIX D. MISCELLANEOUS  .................................................................................................. 168 




LIST OF TABLES 
Table 3.1. Amino Acid Substitutions for All Mutants ................................................... 59 
Table 3.2. Statistical Analysis of PAZ5 Phenotypes with Mounds Included ................. 80 
Table 3.3. Statistical Analysis of PAZ5 Phenotypes with Mounds Excluded ................ 80 
Table A.1.  PAZ5 Sequence (2,256 bp) with Mutant KpnI Site Highlighted  
 (GGTTCC) .................................................................................................... 124 
Table A.2. pTX-GFP Sequence (11,116 bp) with KpnI Ligation Site Highlighted  
 (GGTACC).................................................................................................... 125 
Table A.3. Complete PAZ5/pTX-GFP Fusion Sequence (13,434 bp) with KpnI  
 Ligation Sites Highlighted (GGTACC) .......................................................... 129 
Table A.4. Amino Acid Composition of the PAZ5 Protein ........................................... 134 
Table B.1. Sequence Alignment for Mutant G477Y (1) .............................................. 135 
Table B.2. Sequence Alignment for Mutant C506A (2)............................................... 136 
Table B.3. Sequence Alignment for Mutant C509G (3) .............................................. 137 
Table B.4. Sequence Alignment for Mutant D475A (4) .............................................. 138 
Table B.5. Sequence Alignment for Mutant T628A (5) ............................................... 139 
Table B.6. Sequence Alignment for Mutant C523G (6) .............................................. 140 
Table B.7. Sequence Alignment for Mutant E631A (7) ............................................... 141 
Table B.8. Sequence Alignment for Mutant P514A (8) ............................................... 142 
Table B.9. Sequence Alignment for Mutant R516P (9) ............................................... 143 
Table B.10. Sequence Alignment for Mutant W536L (10) ............................................ 144 




Table B.12. Sequence Alignment for Mutant G542S (12) ............................................. 146 
Table B.13. Sequence Alignment for Mutant F549V (13) ............................................. 147 
Table B.14. Sequence Alignment for Mutant F549S (14) ............................................. 148 
Table B.15. Sequence Alignment for Mutant H519L (15) ............................................. 149 
Table B.16. Sequence Alignment for Mutant F530S (16) ............................................. 150 
Table B.17. Sequence Alignment for Mutant Q546L (17) ............................................. 151 
Table C.1. PAZ5/PTX-GFP Sequence Alignment for Mutant G477Y (1) ...................... 152 
Table C.2. PAZ5/PTX-GFP Sequence Alignment for Mutant C506A (2) ...................... 153 
Table C.3. PAZ5/PTX-GFP Sequence Alignment for Mutant C509G (3) ...................... 154 
Table C.4. PAZ5/PTX-GFP Sequence Alignment for Mutant D475A (4) ...................... 155 
Table C.5. PAZ5/PTX-GFP Sequence Alignment for Mutant T628A (5) ...................... 156 
Table C.6. PAZ5/PTX-GFP Sequence Alignment for Mutant C523G (6) ...................... 157 
Table C.7. PAZ5/PTX-GFP Sequence Alignment for Mutant E631A (7) ...................... 158 
Table C.8. PAZ5/PTX-GFP Sequence Alignment for Mutant P514A (8) ...................... 159 
Table C.9. PAZ5/PTX-GFP Sequence Alignment for Mutant R516P (9) ...................... 160 
Table C.10. PAZ5/PTX-GFP Sequence Alignment for Mutant W536L (10) ................... 161 
Table C.11. PAZ5/PTX-GFP Sequence Alignment for Mutant N538I (11) ..................... 162 
Table C.12. PAZ5/PTX-GFP Sequence Alignment for Mutant G542S (12) .................... 163 
Table C.13. PAZ5/PTX-GFP Sequence Alignment for Mutant F549V (13) .................... 164 
Table C.14. PAZ5/PTX-GFP Sequence Alignment for Mutant H516L (15) .................... 165 
Table C.15. PAZ5/PTX-GFP Sequence Alignment for Mutant F530S (16) ..................... 166 




Table D.1. Method for Staining Cellulose-Producing Stalk Cells  




LIST OF FIGURES 
Figure 1.1. Starvation Phase of D. discoideum Life Cycle ................................................. 4 
Figure 1.2. D. discoideum cells undergoing aggregation ................................................ 12 
Figure 1.3. The Motile Slug of D. discoideum ................................................................. 15 
Figure 1.4. The Fruiting Body of D. discoideum .............................................................. 16 
Figure 1.5. Consensus Sequence of D. discoideum DHHC-CRDs to Several  
 Orthologous Domains ................................................................................... 28 
Figure 1.6. BLAST Analysis of PAZ5 Protein .................................................................... 31 
Figure 2.1. Example Analysis of D. discoideum Fruiting Body Development ................. 56 
Figure 3.1. Mutation Creation in PAZ5/pGEM using PCR ............................................... 59 
Figure 3.2. Example of Mutant and Wildtype Sequence Comparison ............................ 60 
Figure 3.3. PAZ5 Before and After Removal of KpnI Site ................................................ 61 
Figure 3.4. Confirmation of PAZ5-KO BLS Insertion ........................................................ 62 
Figure 3.5. Successful Ligation of PAZ5 into pTX/GFP Expression Vector ...................... 64 
Figure 3.6. Clonal Selection via KpnI Digestion for Two PAZ5/pTX-GFP Ligations ......... 66 
Figure 3.7. Clonal Orientation Test via EcoRI Digestion for Two PAZ5/pTX-GFP  
 Ligations ........................................................................................................ 66 
Figure 3.8. Epifluorescence Imaging of PAZ5-KO Cells ................................................... 69 
Figure 3.9. Fluorescent Artifacts Appear with Higher Laser Voltage Regardless of  
 Cell Line ......................................................................................................... 71 
Figure 3.10. Fluorescent Negative Controls ...................................................................... 72 




Figure 3.12. Fluorescent Localization for Positive Control PAZ8-GFP  
 (PAZ8/pTX-GFP) ............................................................................................. 73 
Figure 3.13. Fluorescent Localization for Positive Control pCV5-YFP ............................... 74 
Figure 3.14. Development of Wildtype (AX2) Cells at 48 HPS Across Two Focal  
 Planes ............................................................................................................ 81 
Figure 3.15. Development of PAZ5-KO (Knockout) Cells at 48 HPS Across Two  
 Focal Planes ................................................................................................... 82 
Figure 3.16. Development of T628A (5) Cells at 48 HPS Across One Focal Plane ............ 83 
Figure 3.17. Development of C523G (6) Cells at 48 HPS Across One Focal Plane ............ 84 
Figure 3.18. Development of R516P (9) Cells at 48 HPS Across Two Focal Planes ........... 85 
Figure 3.19. Development of H519L (15) Cells at 48 HPS Across Two Focal Planes ......... 86 
Figure 3.20. Development of Wildtype (AX2) Strain from 0 to 36 HPS ............................ 87 
Figure 3.21. Development of the PAZ5-KO (Knockout) Strain from 0 to 36 HPS ............. 88 
Figure 3.22. Development of T628A (5) PAZ5 Mutant Strain from 0 to 36 HPS ............... 89 
Figure 3.23. Development of C523G (6) PAZ5 Mutant Strain from 0 to 36 HPS .............. 90 
Figure 3.24. Development of H519L (15) PAZ5 Mutant Strain from 0 to 36 HPS ............. 91 
Figure A.1. Restriction Sites of PAZ5 with Mutated KpnI Site ....................................... 122 
Figure A.2. Diagram of the pTX-GFP Plasmid Vector .................................................... 123 







 Eukaryotic organisms utilize a vast array of chemical signals to modulate their behavior 
and the behavior of cells around them; this system of cell stimulus-response is known as signal 
transduction. A common method of cellular signal transduction involves the binding of 
chemicals to receptor proteins that exist as part of the plasma membrane of the cell. Once a 
ligand binds to one of these integral membrane receptors, a signal is sent into the cytoplasm to 
bring about a response from the appropriate effector protein. These signal transduction 
pathways are responsible for coordinating various cellular responses, including changes in 
metabolism, gene expression, cell division, and apoptosis. Studying these cellular signal 
transduction pathways can be performed in several ways. 
The Gundersen lab focuses on the model eukaryotic organism Dictyostelium discoideum, 
a social amoeba that is often used in developmental studies (Annesley & Fisher, 2009; Consalvo 
et al., 2019; Van Haastert & Devreotes, 2004). D. discoideum is a model organism because it 
undergoes a lifecycle that shares many similar genetic, cellular, and biochemical processes of 
more complex organisms, such as mammals. The lifecycle and reproduction of D. discoideum 
involve two significant phases: a trophic phase, where individual cells consume bacteria and 
divide mitotically, and a starvation phase, characterized by multicellular aggregation and 
differentiation (Kessin & Van Lookeren Campagne, 1992). The starvation phase is of great 
interest because it involves hundreds of thousands of cells cooperating to produce a fruiting 




A standard signal transduction pathway, shared by all eukaryotic organisms and used for 
a wide variety of functions, is the G protein-mediated pathway (Lochrie & Simon, 1988). G 
proteins are a family of proteins that act as molecular switches. They are peripheral plasma 
membrane proteins that mediate signals from integral membrane receptor proteins to the cell 
interior. When a ligand signal binds to a G protein complex outside, an inner G protein is 
released to allow effector activation. 
G proteins, along with a wide range of other membrane-bound proteins, use lipid 
modifications to modulate their interactions with other proteins. Lipid modifications involve the 
covalent attachment of a lipid group to a protein, which changes its hydrophobicity and thus its 
affinity for the cellular membranes of protein domains. Different lipid modifications, such as 
palmitoylation or myristoylation, provide different affinities, and multiple lipid modifications 
can modify a single protein. Lipid modifications are ubiquitous in eukaryotes and occur on 
almost a thousand different proteins (Resh, 2013). 
S-Palmitoylation, a widespread lipid modification, is known to regulate G protein 
function (Linder et al., 1993). A family of proteins containing DHHC cysteine-rich-domains has 
been associated with palmitoylation mediation (Greaves & Chamberlain, 2011). The Gundersen 
lab has previously shown that the Gα2 subunit of the G protein controls entry into the 
developmental stage of the D. discoideum life cycle (R. E. Gundersen et al., 2005). The 
Gundersen lab has also shown that the Gα2 subunit localizes through the action of 
palmitoylation (S. Alamer et al., 2018). In D. discoideum, fourteen genes have been identified 
containing DHHC-CRD regions, known as Putative Acyltransferases with Zinc Fingers (gene 




genes may lead to a better understanding of how palmitoylation is performed and how it 
affects cellular signal transduction. 
 
1.1. Dictyostelium discoideum  
 The social amoeba Dictyostelium discoideum is a powerful eukaryotic model organism 
used for developmental studies (Annesley & Fisher, 2009). For over 90 years, D. discoideum has 
been the subject of serious study; in fact, it is the most studied of all the social amoebae, also 
known as cellular slime molds (Kessin, 2001). Despite its relatively simple appearance, it has 
many developmental features in common with more complex eukaryotes. D. discoideum are 
initially found as single vegetative cells living in soil, dividing mitotically, and consuming 
bacteria through phagocytosis. Upon exhausting their local food supply, the cells enter a 
starvation phase, which forces the amoeba to undergo significant developmental changes. The 
cells have two distinct responses to this newfound pressure; they can form either macrocysts or 
fruiting bodies. The fruiting body (sorocarp) process is easily the most studied because it 
manifests features common to all developing organisms (Kessin, 2001). Namely multicellular 
cooperativity, cell specialization and differentiation, and complex intracellular signal 
transduction. 
The cells respond to starvation by sending out chemotactic signals to attract nearby cells 
to aggregate and transform into a multicellular organism capable of undergoing cell 
differentiation and morphogenesis (Kessin, 2001). Through signaling, the cells regulate and 
differentiate themselves into set proportions and patterns, allowing for the creation of a 




structure with a ball of resistant spores at its peak suspended by a stalk comprised of dead 
cellulose-producing cells. A useful consequence of these two developmental stages, 
consumption and starvation, is that genes induced during development are not typically 
needed during mitotic growth. Moreover, if cells undergoing starvation are exposed to food, 
they rapidly revert to the amoeboid stage of growth, in a process known as erasure (Finney et 
al., 1979). These genes can be mutated without affecting the viability of the growing organism 
(Kessin, 2001).  
Figure 1.1. Starvation Phase of D. discoideum Life Cycle. Upon starvation, individual D. 
discoideum cells undergo aggregation into a multicellular mound; this mound then transforms 
into a motile slug. The cells then differentiate into spore and stalk cells, after which they 
culminate into a fruiting body. The fruiting body eventually releases its spore cells, which 





Starvation also induces a slew of new genes that are necessary for the chemotactic aggregation 
response. As a result, the mitotic growth stage provides many advantages in maintenance and 
experimental ease associated with microorganism research. Simultaneously, the starvation 
phase allows for a multicellular perspective comparable to more complex organismal growth.  
Besides its lifecycle, D. discoideum possesses many other useful aspects conducive to 
research. These include its small (3.4 x 107 bp) genome that has been completely sequenced 
(Eichinger et al., 2005) in addition to possessing mitochondria and plasmids, with the 
mitochondria also having been sequenced (Ogawa et al., 2000). By comparison, E. coli and S. 
cerevisiae respectively have a genome size of 4.6 x 106 and 1.2 x 107 bp.  The genome covers a 
haploid set of six chromosomes and has 90% efficient transcription into about 12,500 genes. In 
comparison, the diploid human genome (109 bp) has an efficiency of 10% transcribed with only 
around twice the number of genes, several of which are analogous across both organisms 
(Tatischeff, 2019). In 1999 the National Institute of Health (NIH) chose D. discoideum as one of 
eight non-mammalian model organisms for biomedical research (Koller et al., 2016; Tatischeff, 
2019).  
 
1.1.1. History of Research into D. discoideum 
The genus Dictyostelium was first identified 130 years ago by the mycologist Oskar 
Brefeld. It was so named because Dicty means net-like and stelium means tower, so-called due 
to the aggregation territories resembling nets and the fruiting bodies like towers. Brefeld 
realized that the trophic and fruiting body stages belonged to the same organism. Researchers 




and sometimes enriched with agar; however, they were always contaminated with bacteria 
that the amoeba fed off. It was not until 1903 that the scientist Jean-Paul Vuillemin realized 
that amoeba engulfed the bacteria and that the digestion was intracellular rather than the 
extracellular digestion that fungi were known to use (Kessin, 2001).  
Dictyostelium, as a developmental model, did not see widespread adoption until 1935, 
thanks to the works of Kenneth Raper (Kenneth B Raper, 1935). Raper was the first to isolate D. 
discoideum in soil samples from the hardwood forest of Little Butt’s Gap in Ashville, North 
Carolina; these became the type strain and were labeled NC4. Raper was also the first to begin 
using an agar-based bacterial lawn of Klebsiella aerogenes to grow the amoeba and began a 
sweeping examination of many stages of the D. discoideum lifecycle (Kenneth B Raper, 1940). 
For example, they noted that cells maintained a 20%: 80% proportion of stalk to spore cells 
regardless of aggregate size. They also determined that they would segregate and form 
separate fruiting bodies when mixing different species of amoeba (Kenneth B Raper, 1940). In 
1944 John Tyler Bonner discovered that the aggregation of cells was driven by chemotactic 
molecules (J. T. Bonner, 1944). However, it was not until 1969 that the molecule was 
determined to be cyclic adenosine monophosphate (cAMP). Bonner also determined that the 
chemotactic agent was emitted in a pulsatile manner, such that every 6 minutes, a pulse of the 
signal was released in a steadily increasing gradient to attract the cells (J. Bonner et al., 1969).  
Other significant contributions to D. discoideum becoming recognized as a model 
organism for developmental studies came about in the late 1960s with the independent work 
of Maurice Sussman and Günter Gerisch. Both scientists led the way for molecular biology and 




methods. Sussman used a biochemical approach to determine that gene activation led to 
increases in enzymes for polysaccharide biosynthesis, spearheading the notion that gene 
induction led to enzyme activity changes (R. Sussman & Rayner, 1971). Gerisch pioneered the 
immunological approach in discovering cell adhesion systems in aggregating cells using 
antibodies to block adhesion (Gerisch, 1968). These same approaches were later adapted for 
use in mammalian cells (Kessin, 2001).   
 
1.1.2. Phylogeny and Genomics of D. discoideum  
D. discoideum lies in the Eukaryota superkingdom, Amoebozoa clade, Evosea phylum, 
Eumycetozoa class, Dictyostelia clade, Dictyosteliales order, and Dictyosteliaceae family 
(Schoch et al., 2020). However, the evolutionary biology of D. discoideum is still a source of 
confusion. There is no fossil record for amoeba; instead, molecular phylogenetic techniques 
must be relied upon, such as comparisons of conserved proteins or ribosomal RNAs. There are 
several difficulties with this method. Firstly, phylogenetic inference relies on the assumption 
that there is no lateral gene transfer. When a species has diverged, it no longer exchanges 
genetic material with other divergent species. Unfortunately, this is not the case with D. 
discoideum; for example, it possesses a cyclic nucleotide phosphodiesterase used to control 
cAMP in aggregation with no known homologs in plants or animals but does share homology 
with enzymes from S. cerevisiae. Other domains likely accumulated from lateral gene transfer 
include its ability to degrade bacterial walls using dipeptidase and to survive the effects of 
tellurite in its soil environment (terD) (Eichinger et al., 2005). A second problem with 




duplication event within the same genome. It then leads to difficulty separating the 
evolutionary history of species from the evolutionary history of individual genes, though, in 
recent years, this problem has been somewhat ameliorated (Hellmuth et al., 2015). However, it 
is known that the Amoebozoa clade diverged from the animal-fungal lineage after splitting from 
the plant-animal lineage (Eichinger et al., 2005). Suffice to say, D. discoideum diverged a very 
long time ago, though precisely when is still up for debate depending on preferences toward 
either protein or ribosomal sequence analysis (Romeralo et al., 2011; Schilde et al., 2019).  
The genome of D. discoideum is relatively small but is extremely rich in A-T nucleobases, 
especially in intergenic regions and introns (Kessin, 2001). The introns are around 100 bp and 
are found in many genes. The genome covers a haploid set of six chromosomes and has 90% 
efficient transcription into about 12,500 genes. Despite having a compact genome of only 
12,500 transcribed genes, D. discoideum can operate one of two developmental cycles, 
macrocysts or fruiting body formation. D. discoideum is also able to produce all it needs, save 
for a carbon source, eight amino acids, and a few vitamins (Franke & Kessin, 1977). The base 
composition is 77% AT, while in coding sequences A and T make up around 65% (Kessin, 2001). 
Coding sequences also have an AT bias, such that if the third position of a codon can be an A or 
T, it typically is. Moreover, coding sequences often have long repeats of the AAC triplet in all 
reading frames, producing extensive lengths of Asparagine (AAC), Glutamine (CAA), and 
Threonine (CAA), though their function is as yet unknown (Erber et al., 2020; Shaw et al., 1989).  
An important issue with the genome of D. discoideum results from its ability to 
accumulate random chromosomal changes, such as duplications, during its serial passage. 




from different laboratories can have different duplications (Bloomfield et al., 2008). These 
variations, especially when unknown, may result in phenotypic differences across strains. It may 
also make genetic manipulation, especially knockouts, more problematic as two loci could 
target instead of one.  
There are two major axenic strains used in laboratories today, AX2 and AX3/4; both 
were created independently in the 1970s through repeated sub-culturing of the original 1933 
NC4 D. discoideum type strain that grew well in complex media (HL-5) (Franke & Kessin, 1977; 
Schwalb & Roth, 1970). In comparison to NC4, the axenic strains grow slower on bacteria and 
produce smaller fruiting bodies (Bloomfield et al., 2008). The AX1 line was generated from the 
original NC4 type strain. The AX2 line was generated from AX1, though AX1 was lost soon after 
the generation of the AX2 line. The AX3 line, independently created from NC4, was re-labeled 
AX4 in the 1980s. As a result, AX2 and AX3/4 are the two significant strains (DictyBase, 2000). 
The AX4 strain was eventually sequenced in 2002, mainly because most of the genome had 
previously been transcribed into a yeast artificial chromosome (YAC) map for AX4. The YAC map 
consisted of approximately 1,000 YACs, each containing 200 kb of sequence with 5-fold 
redundancy. The resulting YACs could be overlaid and aligned with one another to produce a 
larger contig (contiguous set of overlapping DNA); these were then used to compare and 
correlate genomic sequencing data with a solid footing (Kuspa et al., 1992; Loomis et al., 1995).  
At the time of sequencing the AX4 genome, it was known that there were duplications 
on the chromosomes of both major strains, duplications that went unnoticed until the 
compiling of the YACs in the 1990s.  For example, the published genome of AX4 has a large 750 




NC4 type strain. AX2 also has a 26 kb duplication on chromosome 1. The original NC4 lines also 
contain duplications as the oldest original stocks were only lyophilized in 1969, 30 years after 
first being isolated. Fortunately, it is still possible to go to the original forest in Ashville, North 
Carolina, and isolate ‘true’ wild-type strains without apparent duplications. It is thereby 
suggested that the duplications may arise from problems inherent to laboratory sub-culture 
technique and growth practices associated with the instability of the AT-rich D. discoideum 
genome (Kessin, 2001).  
 
1.1.3. Developmental Lifecycle of D. discoideum  
The developmental lifecycle of D. discoideum is known almost exclusively from 
laboratory observations (Kenneth Bryan Raper, 1984). In a scientific setting, amoebae are 
grown either on sterile agar plates, sterile agar plates with bacterial lawns, or in a sterile liquid 
medium. When analyzing the lifecycle, amoebae are typically grown on sterile agarose plates 
composed of minimal media. Rarely, the amoebae are grown on sterile soil to mimic starvation 
in its natural environment better, although this method makes it hard to compare samples. 
During the trophic stage of growth, individual amoebae use a chemotactic mechanism 
to interpret their surroundings. The chemotactic capacity of these cells has been compared to 
leukocytes as they both share similar chemotactic detection, signal transduction pathways, 
cytoskeleton mobilization, and macrophagy (Devreotes & Zigmond, 1988; Jin et al., 2009). In 
leukocytes, such as neutrophils, the chemotactic receptors are evenly distributed around the 
cell; they also do not concentrate at one spot during chemotaxis. The primary focus of which 




plasma membrane. The amoebae move rapidly without forming focal adhesions to the 
substratum (Tarantola et al., 2014).  
When the cells of D. discoideum are confronted with imminent starvation, they take 
immediate action. Processes associated with growth come to a halt, the cell cycle stops, and 
transcripts used for growth disappear. Regarding the cell cycle, D. discoideum lacks a G1 phase; 
instead, cells go through mitosis and immediately enter the S phase before spending a long 
period in G2. During starvation, chromosomal DNA synthesis stops, such that cells undergoing 
the G2 phase stop regardless of their proximity to the G2-M boundary. These cells are more 
likely to differentiate into pre-spore cells (Shaulsky & Loomis, 1995). The organism switches to 
metabolic reserves stockpiled during the trophic phase in anticipation of new protein synthesis. 
Within hours, D. discoideum will begin producing proteins used for chemotaxis, both in 
signaling and response, and for aggregation (Kessin, 2001).  
 The primary molecule used for chemotaxis in D. discoideum is cyclic adenosine 
monophosphate (cAMP). The cAMP is produced from ATP by adenylyl cyclase. The ability to 
produce, release, detect, and degrade cAMP is imperative for aggregation, and the entire 
chemotactic process only occurs during the starvation phase (Kessin, 2001). At around 6 hours, 
a few sporadic amoeba cells will begin releasing cAMP into the nearby population; as the cAMP 
is detected by nearby cells, they move closer to the source and release their own pulse of 
cAMP. This subsequent pulse is stronger than the initially received pulse and encourages more 
outward cells to move inward; the pulses continue to re-occur every 6 minutes. Cells only move 
for about 60 seconds and only when the gradient is positive, discouraging movement in the 




stepwise fashion. This wave manifests as circular or spiral patterns that eventually form into 
streams of cells; as these cells aggregate, they become adhesive, forming a loose aggregate 
(Figure 1.2); they eventually move from this loose aggregate and form a three-dimensional 
mound structure. If the cells are disaggregated, they will rapidly reaggregate in one-tenth of the 
original aggregation time (Finney et al., 1979). The process from single cells entering starvation 
to forming the mound takes 8 hours; the resulting mound comprises between 105-106 cells 
(Kessin & Van Lookeren Campagne, 1992).  
  
Figure 1.2. D. discoideum cells undergoing aggregation. D. discoideum cells are seen 
aggregating and forming streams on DB agar at 5.5 hours post-starvation (hps). Pictured using a 





The genome of D. discoideum contains 55 genes that code for GPCRs, belonging to four 
of the six mammalian GPCR families (Prabhu & Eichinger, 2006). There are 12 genes encoding 
for Gα subunits, but only single genes encoding for Gβ and Gγ (Pergolizzi et al., 2017). The 
primary GPCR receptors that bind cAMP in D. discoideum are in the cAR family, a group of 
seven-transmembrane domain (7-TMD) receptors that activate an associated heterotrimeric G-
protein (Consalvo et al., 2019). Four different cAMP receptors, cAR1-4, are expressed 
sequentially during development (Kim et al., 1998). These chemotactic cAR receptors are evenly 
distributed on the cell plasma membrane. cAR1 was the first to be identified and is the primary 
receptor involved in cAMP chemotaxis (Consalvo et al., 2019, 2019). cAR1 and cAR3 have higher 
affinities for cAMP than cAR2 and cAR4 (Ginsburg & Kimmel, 1997). Of the 12 Gα subunits in D. 
discoideum, the Gα2 subunit controls many genes known to be necessary to aggregation; car1 
signaling itself is mediated by the Gα2βγ subunit (Pergolizzi et al., 2017). Gα2 is highly 
developmentally regulated, directly bound to the cAMP receptor, and is maximally expressed 
during aggregation (Kumagai et al., 1989). An immediate response made by cAR1 binding to 
cAMP is the activation of Ras. Activated Ras then triggers adenylyl cyclase to create more cAMP 
from metabolic energy reserves of ATP. Most of the cAMP is then released into the local 
environment around the cell; this cAMP is then used to signal more cells via the same 
chemotactic mechanism, known as the cAMP relay (Kortholt et al., 2011).  
The gradient response for cAMP movement and direction is very fine. D. discoideum, if 
placed in a gradient, will extend pseudopods towards the area with the highest concentration 
of cAMP (Kessin, 2001); moreover, these differentials in cAMP concentration can be as small as 




most occupied cAMP receptors, subtracting one side versus another; the cell focuses on the 
absolute difference in receptor activation, in a process known as adaptation (Theibert & 
Devreotes, 1986). This difference has been theorized to be as small as 250 receptors out of 
40,000 to 200,000 (Mato et al., 1975). The speed of cells moving up a gradient is about 10 
μm/min, or one cell diameter per minute (Kessin, 2001). Despite the even distribution of 
chemotactic receptors on the cell surface, the ability to move is confined to specific areas of the 
cytoskeleton. This directional sensing is mediated by a G-protein linked pathway that uses a 
pleckstrin homology (PH) domain to bind the Gβγ subunit. These PH domains are induced on the 
side of the cell that faces the higher concentration of cAMP, eventually leading to the extension 
of the pseudopod and movement of the cell in that direction (Parent & Devreotes, 1999; N. 
Zhang et al., 2001). Subsequently, the uropod at the back of the cell is retracted by the 
movement of the PH domain away from that side (Van Haastert & Devreotes, 2004).   
Following chemotactic aggregation, the cells in the mound form a sheath layer 
composed of mucopolysaccharide and cellulose. However, not all cells will aggregate during 
starvation. Up to 15% of cells will not aggregate into the mound stage, which is significant at a 
population level. It has been hypothesized that these third-fate cells have an advantage in 
resuming growth if exposed to new nutrients (Dubravcic et al., 2014). The mound then forms an 
anterior tip, which organizes the cells behind it and controls further development. The tip 
triggers the aggregate to elongate, forming a standing slug. From here, the standing slug can 




process of fruiting body formation, known as culmination. The slug movement is controlled by 
the anterior tip, which is both photo- and thermo-tactic.  
 
At this stage, cells differentiate into either pre-stalk or pre-spore, based on their stage in 
the mitotic division cycle (M-S-G2). The pre-stalk proportion to pre-spore cells is typically 20%: 
80% (Kessin, 2001). However, neither differentiation is necessarily permanent, as cells can 
convert between precursor populations or even revert to individual amoeba again. Precursor 
transmutation is typically due to a change in proportion between the two populations, and 
reversion occurs if food is given, ending the starvation phase. The different precursor cell 
populations then move to the top or bottom of the aggregate, such that pre-stalk cells move to 
the top and pre-stalk cells to the bottom.  
Figure 1.3. The Motile Slug of D. discoideum. The motile slug is composed of pre-stalk and pre-






The multicellularity of the aggregated body, arising from a collection of single cells, 
raises the question of how precursor selection operates with a population of genetically distinct 
cells. The mound could be recognized as a chimeric rather than a homogenous or clonal 
assortment of cells. It is known that different species of Dictyostelium, when placed together, 
will re-segregate and form separate fruiting bodies (J. E. Strassmann et al., 2000). Yet it is still 
unknown how the cells determine degrees of relatedness; or how such a clonal organism deals 
Figure 1.4. The Fruiting Body of D. discoideum. The fruiting body represents the final stage of 
the starvation lifecycle. The pre-stalk cells have died to form the stalk, and the pre-spore cells 





with individual cells that stray farther from the clonal norm, especially considering how 
development relies on intracellular cooperation (Joan E. Strassmann & Queller, 2011). This 
intracellular cooperation also leads to the question of the aggregate avoids internal parasitism, 
exemplified by the notion of cheater cells. Cheater cells are cells that may avoid the stalk cell 
fate because of a mutation or defect (Matapurkar & Watve, 1997). These cells would likely have 
a strong evolutionary advantage and lead to a more heterogeneous population; hence it has 
been hypothesized that D. discoideum may have some mechanism for policing itself (Khare & 
Shaulsky, 2010).  
The stalk is formed when pre-stalk cells release and deposit cellulose as they die, then 
they are moved through a narrow collar at the tip of the aggregate to form a stalk tube (Blanton 
et al., 2000). The pre-spore cells then encapsulate themselves in a layered wall of 
mucopolysaccharide and cellulose to form the spore. The pre-spore cells are then moved 
upwards as the stalk is being created around them (Jermyn & Williams, n.d.). The process lasts 
between 8-10 hours, and the resulting fruiting body typically reaches a height of 1-2 mm tall. 
The spores can then be released either into the air or onto the body of a passing animal, such as 
a predatory nematode. These spores then become myxamoebae, ready to begin the lifecycle all 
over again.   
 
1.2. G Protein Signaling  
G proteins, or guanine nucleotide-binding proteins, are members of a larger group of 
enzymes called GTPases. GTPases are a large family of enzymes that bind to guanosine 




The G protein commonly refers to two different families of protein. G proteins can either exist 
as a heterotrimeric G protein complex, made up of alpha (Gα), beta (Gβ) and gamma (Gγ) 
subunits; or as small monomeric GTPases, which are akin to the individual Gα subunit but 
function as independent monomers. G-protein-linked receptors (GPCR) constitute a significant 
class of transmembrane proteins involved in signal transduction. All eukaryotes use G proteins 
for signaling. GPCRs all display a seven-transmembrane domain topology, with an extracellular 
N-terminus, three intracellular and three extracellular loops, and a final intracellular C-terminus 
(Rosenbaum et al., 2009). A GPCR is activated when a specific ligand binds and induces a 
conformational change in the receptor. Ligands can bind to either an extracellular N-terminal 
loop or a binding site within the transmembrane domain (Trzaskowski et al., 2012). Ligands can 
range in size from small peptides to large proteins, as GPCRs are responsible for regulating 
various processes.  
Heterotrimeric G proteins, also known as ‘large’ G proteins, are G proteins associated 
with GPCRs on the cell plasma membrane, forming a heterotrimeric complex (Rosenbaum et al., 
2009). When a ligand binds to a membrane-bound GPCR attached to a heterotrimeric G 
protein, it induces a conformational change in the receptor. This change allows for the 
guanosine diphosphate (GDP) molecule linked to the G protein to be replaced with guanosine 
triphosphate (GTP). The Gα subunit, which binds the GDP, then detaches from the Gβ and Gγ 
subunits upon GTP binding; both separated subunits can trigger an associated response within 
the cell (Grisshammer et al., 2005). Subsequent hydrolysis of the GTP to GDP then ends this 
signal. This hydrolysis effectively makes the GTP/GDP an ‘on/off’ switch for the G protein. The 




the lessening of a response after persistent stimulation. If desensitization occurs without loss of 
plasma membrane receptors, this is called adaptation. If receptor molecules are destroyed, the 
process is known as down-regulation. Finally, if receptors are removed but not destroyed, this 
is known as sequestration. 
Small monomeric GTPases, also known as ‘small’ G proteins or Ras GTPases, are a family 
of related enzymes that can bind and hydrolyze GTP. Small GTPases are responsible for 
regulating several critical cellular processes, including cytoskeletal control, cell proliferation, 
membrane trafficking, and cell division, among others. All small GTPases belong to the Ras 
superfamily, so-named because the superfamily founding members are encoded by human Ras 
genes that were homologous to the viral ras oncogene (Yang, 2002). Homologous to the Gα 
subunit, small GTPases can function independently of the Gβ and Gγ subunits, able to hydrolyze 
GTP to GDP (Paduch et al., 2001). Unlike the heterotrimeric G proteins bound to GPCRs on the 
plasma membrane, small GTPases are soluble. Like Gα proteins, small GTPases alternate 
between an ‘on' state (bound to GTP) and an 'off' state (bound to GDP) (Hepler & Gilman, 
1992). All small GTPases contain four conserved domains for guanine nucleotide-binding and an 
effector domain (Yang, 2002). The Ras superfamily of small GTPases is composed of five main 
families that are generally responsible for different signal pathways: Ras for cell proliferation, 
Rho for cytoskeletal dynamics and cell morphology, Rab for membrane trafficking, Rap for 
cellular adhesion, and Arf for vesicular transport (Goitre et al., 2014). Due to the wide variety of 
important roles that small GTPases are involved with, insight into their functional mechanisms 




The G protein subunits Gα and Gγ can undergo lipid modifications, wherein a lipid moiety 
is attached to the protein, altering their hydrophobicity and allowing the modified protein to 
localize to different cellular compartments depending on their role. Such as the endoplasmic 
reticulum, Golgi apparatus, and plasma membrane (Sobocińska et al., 2018). An essential lipid 
modification in G protein function is palmitoylation, the lipid modification involving the 
attachment of a palmitic acid moiety to cysteines of substrate proteins. The linkage is a 
thioester bond and is reversible (De & Sadhukhan, 2018). Palmitoylation is often used to 
enhance protein-membrane localization in conjunction with other, non-reversible, lipid 
modifications. 
G-proteins are essential to many cellular processes, and their malfunction is associated 
with a swathe of diseases. There are several different subtypes of G protein subunits; in 
humans, there are 18 Gα, 5 Gβ, 12 Gγ subunits, and numerous small GTPases (Heng et al., 2013). 
GPCRs are also an important drug target, with almost 50% of drugs on the market targeting 
GPCRs (Trzaskowski et al., 2012). Consequently, a significant amount of research has and 
continues to be performed in understanding the mechanisms and function of G-proteins and 
their involvement in signal transduction.  
 
1.3. Lipid Modifications  
 G-protein membrane localization, function, and targeting are dependent on several 
specific lipid covalent modifications. Attachment of lipid groups occurs on almost a thousand 
different proteins (Resh, 2013). Proteins are typically much larger than lipids, so while the 




substantial change to the localization and subsequent fate of the protein. Lipid modifications 
are classed based on the type of attached lipid, including prenylation, myristoylation, GPI-
anchored proteins, and palmitoylation (Casey, 1995). The type of lipid modification used 
produces a specific property. It provides a vital role for a diverse array of processes for 
substrate proteins, such as membrane trafficking. Proteins can also contain more than one type 
of lipid attachment allowing for different levels of hydrophobicity, and therefore membrane 
specificity. 
 Prenylation involves the post-translational covalent attachment of either a farnesyl (15-
carbon) or a geranylgeranyl (20-carbon) isoprenoid moiety to a conserved C-terminal (COOH) 
cysteine residue of the target protein (F. L. Zhang & Casey, 1996). Prenylation takes place in the 
cytoplasm of the cell and is commonly used in the process of attaching to the plasma 
membrane. These two similar lipids are attached via one of three different enzymes: 
farnesyltransferase, geranylgeranyltransferase I, or CaaX protease. These enzymes are chosen 
based on their presentation with the CaaX box, where ‘C’ is the cysteine to be prenylated, ‘a’ is 
an amino acid containing an aliphatic side chain, and X is the type of amino acid that 
determines which moiety will be used. Such a farnesyl will modify x = A, C, M, Q or S, the C; on 
the other hand, if X = E or L, a geranylgeranyl will be attached. The process results in a stable 
modified protein. Prenylation also occurs in small G-proteins that lack the CaaX motif; instead, 
they have two C-terminal cysteine residues that undergo prenylation by the addition of 
geranylgeranyl. After prenylation, most proteins are further processed by cleaving the aaX 
residues from the newly created prenyl-cysteine. This prenyl-cysteine can then be further 




the attachment of a second signal allows for the possibility of reversible association (Casey, 
1995; Clarke, 1992).   
Glycosylphosphatidylinositols (GPI)-anchored proteins are a variety of cell surface 
proteins that do not cross the plasma membrane into the cytoplasm yet are still a kind of signal 
transduction molecule. It is estimated that 1% of eukaryotic proteins are modified by GPI-
anchored proteins (Resh, 2013). GPI anchored proteins involve the post-translational 
attachment of a phosphoglyceride to the C-terminal amino acid of a protein. Unlike more 
straightforward lipid modifications, the GPI anchor has a much more complex structure. The 
GPI contains a phosphatidylinositol composed of mannose and glucosamine glycosidically 
attached to an inositol residue; the attachment to the C-terminus is made through an 
ethanolamine phosphate bridge (Paulick & Bertozzi, 2008). The GPI linkage is also reversible 
and can be broken down by phospholipases. It has also been shown that the GPI anchor can 
jump from one cell to another via intermembrane transfer (Resh, 2013).  
 Myristoylation is generally a co-translational process, which takes place at the ER. It is 
estimated that 0.5-0.8% of eukaryotic proteins are myristoylated (Resh, 2013; Wolven et al., 
1997). Myristoylation involves the covalent attachment of a myristoyl (14-carbon) group in an 
amide bond to an N-terminal (NH2) glycine residue (Boutin, 1997). Typically, proteins to be 
myristoylated contain the sequence MGxxxS/T. The addition of the myristoyl group is catalyzed 
via the N-myristoyltransferase enzyme, after which it also results in a stably modified protein. 
However, in rare situations, the myristoyl moiety can be cleaved from the myristoyl-glycine 
(Manenti et al., 1994). Myristoylation provides for weak protein-protein and protein-lipid 




signal transduction pathways. Myristoylated protein often undergoes other lipid modifications, 
such as palmitoylation, to enhance their hydrophobicity and increase affinity for other specific 
localizations (Farazi et al., 2001).  
Palmitoylation is the post-translational covalent attachment of a palmitic acid (16-
carbon) residue to either a cysteine via a thioester bond (S-palmitoylation) or a serine and 
threonine (O-palmitoylation), via an ester bond (Greaves & Chamberlain, 2011). Palmitoylation 
typically involves membrane or transmembrane proteins and is used to enhance their 
hydrophobicity for various processes, such as protein trafficking, plasma membrane 
localization, protein assembly, and as a stability factor (Linder & Deschenes, 2007). Unlike 
prenylation and myristoylation, palmitoylation is reversible due to its thioester linkage and can 
be broken down through the actions of palmitoyl protein thioesterases (PTEs). On the other 
hand, while prenylation and myristoylation linkages cannot be physically removed, they can be 
sequestered via a hydrophobic cleft (Resh, 2013). The thioester linkage's ability to be reversed 
allows for dynamic cycles of palmitoylation and depalmitoylation to occur; many of these 
enzyme cycles have been characterized, such as H-Ras, the β2-adrenergic receptor, the G-
protein Gα subunit, and endothelial nitric oxide synthase (Lynch et al., 2015). An especially 
prominent usage of palmitoylation cycling is in PSD-95, a postsynaptic density protein, which is 
dynamically regulated in synaptic activity, suggesting that palmitoylation has a role in regulating 
neurotransmitter release (Fukata et al., 2004). 
N-palmitoylation is a comparatively rare form of palmitoylation that occurs in hedgehog 
(Hh) protein. Unlike S-palmitoylation, N-palmitoylation involves an amide bond between the 




unlike S-palmitoylation, N-palmitoylation is an irreversible modification. N-palmitoylation is 
uniquely catalyzed by the multipass hedgehog acyltransferase (Hhat). Uniquely, it is also 
modified via the covalent attachment of cholesterol to its C-terminus using an ester bond. Hh 
proteins specifically localize to the lumen of the ER.  
 
1.4. S-Palmitoylation and the DHHC Domain 
The vast majority of palmitoylated proteins are modified via S-palmitoylation; in fact, up 
to 3500 human proteins are known to be S-palmitoylated (Blanc et al., 2015); S-palmitoylation 
is also the focus of this study. The enzymes that perform S-palmitoylation are the post-
translational covalent attachment of a palmitic acid (16-carbon) residue, to cysteine via a 
thioester bond. These palmitoyl thioester linkages have been known to occur spontaneously in 
vitro in the presence of palmitoyl-CoA at neutral pH (Bharadwaj & Bizzozero, 1995). However, 
S-Palmitoylation is primarily catalyzed by a family of cysteine-rich domain, thiol-directed, 
protein acyltransferases (PATs, or DHHC-PATs). These PATs contain a highly conserved 50-
amino acid sequence known as the DHHC domain due to its Asp-His-His-Cys tetrapeptide motif 
in the active site. While S-palmitoylation was discovered almost 50 years ago, identification of 
the enzymes responsible and the associated DHHC domain was only confirmed in 2002 (Lobo et 
al., 2002; Roth et al., 2002). Examples of PATs that include this DHHC domain include the yeast 
PATs Erf2/Erf4 that palmitoylate prenylated Ras, Pfa4, the PAT that regulates the transit of 
yeast chitin synthase Chs3, and the PAT for yeast casein kinase II, Akr1 (Lam et al., 2006; 




Recent studies in yeast and mammalian cell lines suggest that DHHC proteins use a two-
step, or ping-pong, catalytic process; this process is generally accepted to apply to most DHHC 
proteins, albeit not in Swf1 and Pfa4 (Gottlieb & Linder, 2017). During the first step, DHHC auto-
acylates via a palmitoyl-CoA donor to form an acyl-enzyme intermediate. In the second step, 
palmitate is transferred to the substrate protein. Thanks to mutational analysis of the DHHC 
motif, it was determined that the first histidine in DHHC is used to transfer palmitate to a 
protein, whereas the cysteine is catalytic and used for autoacylation (Jennings & Linder, 2012; 
Mitchell et al., 2010). 
The DHHC-PATs are responsible for S-palmitoylation in a variety of organisms ranging 
from yeast (7 DHHC family members in Saccharomyces cerevisiae) to D. discoideum (14 DHHC 
family members) to humans (23 DHHC family members) (Lemonidis, Werno, et al., 2015). Genes 
encoding DHHC proteins have been found in all eukaryotic genome databases (Mitchell et al., 
2006). However, no prokaryotes or archaea have been discovered with DHHC-PATs, though 
certain bacteria can co-opt the hosts DHHC-PATs to palmitoylate their proteins. DHHC proteins 
are expressed in various tissues and even different subcellular locations (Linder & Deschenes, 
2004). The DHHC PATs are multi-pass polytopic membrane proteins with 4-6 transmembrane 
domains; they localize to the ER, Golgi, and plasma membrane. The palmitate is transferred 
from palmitoyl CoA to the protein of interest via an acyl-enzyme intermediate. Some proteins 
are modified by a single DHHC, whereas multiple DHHC PATs may modify others at different 
times (De & Sadhukhan, 2018).  
Protein palmitoyltransferases were initially isolated in S. cerevisiae in the search to 




Ras proteins, yeast Ras required several lipid modifications to localize properly as a signal 
transducer. It had previously been shown that a farnesyl moiety was added to the Ras, but this 
would not have provided the necessary hydrophobicity for localization to the plasma 
membrane; instead, a second signal in the form of a palmitoyl group enhanced the protein 
(Boyartchuk et al., 1997; Hrycyna & Clarke, 1990). Initially, a non-enzymatic reaction was 
suggested as isolating the PAT proved unsuccessful, especially as palmitoyl CoA had been 
shown to react to proteins on its own given the required conditions. The key to elucidating the 
identity of the palmitoyltransferases came with studies of the Ras2 allele and the discovery of 
the ERF (Effectors of Ras Function) mutations (Bartels et al., 1999; Jung et al., 1995).  
Ras2 had been isolated because of its propensity to localize after palmitoylation but 
without the need to be prenylated beforehand via a C-terminal amino acid residue (Kataoka et 
al., 1984). Subsequently, PAT contenders were isolated from yeast mutations that were 
screened in the presence of Ras2, that mutations that proved fatal were isolated. Ras2 was 
solely dependent on palmitoylation, so mutants that died were those that effectively reduced 
or blocked palmitoylation; these mutants were labeled ERF mutations, ERF1, ERF2, and ERF4 
(Bartels et al., 1999). Further studies on these mutations discovered that Erf2 and Erf4 co-purify 
as a complex and that to provide Ras PAT activity, both had to be present as a heterodimer 
(Zhao et al., 2002). Such that Erf2 possesses the four transmembrane domains, and Erf4 is 
attached to TM4 but sits exclusively in the cytoplasm. An immediately characterized aspect of 
Erf2 was the DHHC domain located between the second (TM2) and third (TM3) transmembrane 
domains; when the yeast genome was searched for this domain, it showed up in seven other 




such as Akr1 and Pfa3 (Roth et al., 2002, 2006). Of interesting note is the DHYC domain in Akr1, 
which replaces the second histidine in DHHC with a tyrosine; its ability to autoacylate and 
palmitoylate does not seem to be affected as it is missing the two zinc-finger motifs common in 
other DHHC domains (Figure 1.5). The high degree of sequence homology across DHHC 
domains makes it possible to test and study, possibly even determining similar palmitoylation 
pathways across various eukaryotes. Despite knowledge of the DHHC-PATs, high-resolution 
structures have only recently been three-dimensionally mapped; Primarily due to the difficulty 
in purifying a eukaryotic multi-pass transmembrane protein to determine its structure (Rana et 
al., 2018).  
The 51-amino acid domain surrounding the DHHC tetrapeptide motif is so-named the 
Cysteine Rich Domain (CRD) due to the high number of conserved cysteine residues flanking the 
motif. The DHHC-CRD is typically found between TM2 and TM3, which puts it on the cytosolic 
side of the plasma membrane; the N-terminus before the TM1 and the C-terminus after TM4 
are also in the cytosol (Mitchell et al., 2006). The original DHHC-CRD consensus sequence was 
obtained from a Drosophila melanogaster open reading frame called DNZ1 (Mesilaty-Gross et 
al., 1999; Putilina et al., 1999): C-x2-C-x9-H-C-x2-C-x4-D-H-H-C-x5-C-x4-N-x3-F. However, upon 
further cluster alignments across yeast, humans, and a host of other organisms, a revised 
consensus sequence was determined: 
C-x2-C-x3R/K-P-x-R-x2-HC-x2-C-x2-C-x4-DHHC-x-W-V/I-x-N-C-I/V-G-x2-N-x3-F 
 One clear revelation was that more residues than just the cysteines were conserved in 
the domain. These include, in order, the positively charged arginine or lysine (R/K) at position 8, 




(W) at 31, the hydrophobic valine or isoleucine (V/I) at 32 and 36, the asparagine (N) at 34, the 
glycine (G) at 37, and the phenylalanine (F) at 44. Despite these conserved residues, there is still 
quite a bit of variability in the N- and C-terminals around the DHHC-CRD; this is especially 
apparent with the large size differences between different DHHC genes. This may suggest a 
selective pressure to maintain these conserved residues, especially the cysteines seen across 
practically all organisms. The consensus sequence for the DHHC-CRDs in D. discoideum is 
presented in Figure 1.5. In addition to the conserved residues in the DHHC-CRD, a few other 
Figure 1.5. Consensus Sequence of D. discoideum DHHC-CRDs to Several Orthologous 
Domains. PAZ1-14 are shown with their corresponding DHHC-CRDs, also shown are orthologs in 
yeast, zebrafish, mice, fruit fly, roundworm, and humans. The two CCHC zinc-finger motifs are 
labeled in purple and blue; other conserved amino acids are labeled in red; the DHHC domain is 
black, except for the second histidine, which is part of the second CCHC zinc-finger motif. The 




conserved motifs also appear. A DPG (Asp-Pro-Gly) tripeptide motif is often found near TM2, a 
TTxE (Thr-Thr-x-Glu) tetrapeptide motif near TM4, and palmitoyltransferase conserved C 
terminus (PaCCT) a 16-amino acid motif found at the cytosolic C-terminus that is found in 70% 
of eukaryotic PATs  (González Montoro et al., 2009; Stix et al., 2020). The precise chemical role 
for these motifs still has not been elucidated, but there have been a few insights into their 
structure. For example, the second threonine in the TTxE complex has been shown to interact 
with the aspartic acid of the DHHC motif, though the significance is presently unknown.   
The conserved cysteine residues in the DHHC-CRD have been shown to coordinate zinc 
to maintain the structural integrity of the DHHC protein rather than act in a catalytic function 
(Gottlieb et al., 2015). This lack of catalytic function finds support from the fact that DHHC PATs 
do not need zinc to be as active in their role as PATs, such as in yeast Akr1, which lacks 5 of the 
cysteines seen in other DHHC orthologs (Roth et al., 2002). The DHHC-CRD contains two CCHC 
zinc-finger motifs (Figure 1.5), and previous studies have shown a loss of function when the 
conserved cysteines and histidines are mutated (Hou et al., 2009; Young et al., 2014). A zinc 
finger is a protein structural motif common in all plants and animals. Zinc fingers are a metal-
binding domain that allows for the coordination of one or more zinc ions to stabilize protein 
folding (Laity et al., 2001). There are several types of zinc fingers; in general, they coordinate 
zinc using a combination of cysteine and histidine residues (Laity et al., 2001). There are six 
cysteines and two histidines involved in the two zinc fingers. The conserved cysteines and 
histidines engaged in zinc-coordination are separate from the first histidine and cysteine of the 




zinc-binding sites has also been confirmed and quantified from an active DHHC protein via the 
mag-fura-2 fluorescent indicator (Gottlieb et al., 2015).  
 A subset of DHHC proteins also has ankyrin repeats in the N-terminal region from the 
DHHC motif. A consensus sequence (VIAP-VIT-xxQP) has been identified in the unstructured 
regions of some DHHC proteins. This region allows binding some ankyrin repeats, perhaps 
helping the DHHC access the appropriate cysteine in a substrate protein (Lemonidis, Sanchez-
Perez, et al., 2015). However, it is unknown whether the ankyrin repeats are required for PAT 
activity (Hemsley & Grierson, 2011). Ankyrin repeats are a common structural motif that are 
typically used to mediate protein-protein interactions (Mosavi et al., 2004). Most proteins that 
contain the motif have four to six repeats. The ankyrin fold itself is more recognized for its 
structure than its function, as no specific sequence or structure binds to it in all cases (Mosavi 
et al., 2004). 
S-palmitoylation affects various targets, including small GTPases, receptors, ion 
channels, cell-adhesion proteins, transporters, scaffold proteins, and more. S-palmitoylation is 
consequently crucial for cellular signaling, metabolism, meiosis, and endocytosis. Human-
specific parasites encode DHHC enzymes that are critical to their survival (Jones et al., 2012). 
Pathogenic bacteria can co-opt a host cell’s DHHC enzymes to modify their effector proteins 
before re-injecting them back into the host to proliferate, as bacteria lack their own DHHC-PATs 
(Hicks et al., 2011; Lin et al., 2015). The DHHC-PATs have been linked to various diseases in 
humans ranging from cancer to neuropsychiatric disease (De & Sadhukhan, 2018). S-
palmitoylation is essential for the function of certain oncogenes and tumor suppressors (Ko & 




for example in Alzheimer’s disease (Andrew et al., 2017; Cho & Park, 2016). Two DHHC-PATs 
have recently been suggested as oncogenic targets (Runkle et al., 2016; Sharma et al., 2017). 
Research into S-palmitoylation, PATs, and the associated DHHC domain has a bright future.  
 
1.5. The PAZ5 Protein/pazE Gene  
 BLAST analysis was performed on the D. discoideum genome using the DHHC motif 
(Figure 1.6). Fourteen D. discoideum proteins and associated transcribed genes were 
discovered, each containing a DHHC-CRD (Bodwell, 2007). These were designated Protein 
Acyltransferase with a Zinc finger-like domain (Bodwell, 2007). The proteins were labeled PAZ1-
14, and the reflective genes were labeled pazA-N (S. Alamer et al., 2018).  
 
 
BLAST analysis of PAZ5 is seen in Figure 1.6, showing the DHHC-CRD and the presence of 
6 ankyrin repeats. PAZ5 contains two conserved CCHC zinc-finger residues, a conserved DPG 
motif, and a conserved TTYE motif. PAZ5 has a predicted total of 6 transmembrane domains. It 
has also been predicted to localize to the Golgi membrane. The DHHC motif of PAZ5 has 
previously been mutated; the resulting mutations caused slowed growth and malformations in 
the fruiting body stage of the D. discoideum lifecycle (Amburg, 2010). Two PAZ5 knockouts 
were created, which mutated the first histidine and the cysteine in the DHHC domain. The 
Figure 1.6. BLAST Analysis of PAZ5 Protein. BLAST analysis shows the Ankyrin and DHHC 




resulting phenotypes had cell sorting issues, such that fewer than normal cells differentiated 
into cellulose-producing stalk cells. The resulting fruiting bodies collapsed under their own 
weight and continued to grow along the agar surface. Upon rescue with the wildtype, stalk 
malformations ceased, and cells grew normally (Amburg, 2010).  The pazE gene (PAZ5 protein) 
was initially chosen for further study as it possessed no introns in its domain. Previous work has 
discovered that mutations in the DHHC motif of the pazE gene cause a characteristic deformity 
in the fruiting body formation of D. discoideum (Amburg, 2010). This deformity manifests as 
slowed growth and an inability for the stalk to stand on its own. It appears the stalk, which is 
usually composed of dead stalk cells 3-5 cells thick, is instead only 1-2 cells thick and collapses 
under its own weight. PAZ5 is 2256 bp and is located on the second chromosome, from 
coordinates 5060014 to 5062269. PAZ5 is 751 amino acids in length and has a molecular weight 
of 85,828 Da. The Dictybase accession number for PAZ5 is DDB_G0275097, and the UniProt 
accession number is Q554E7 (ZDHC5_DICDI). 
 
1.6. Rationale 
 The Gundersen lab’s focus has primarily been to study the signal transduction pathways 
associated with the heterotrimeric G protein using the model organism D. discoideum, 
specifically the effect and mediation of palmitoylation of the Gα2 subunit. The Gundersen lab 
has previously found evidence that the Gα2 subunit of the G protein is essential to the 
developmental lifecycle of D. discoideum, as loss of function of the Gα2 subunit leads to cells 
failing to enter the developmental phase (R. E. Gundersen et al., 2005). The Gα2 subunit 




E. Gundersen, 2001). The Gα2 subunit has been implicated as the major transducer between cell 
surface cAMP receptors and the associated intracellular responses within the cell (R. Gundersen 
& Devreotes, 1990). G protein-membrane localization, including the Gα2 subunit, is dependent 
on lipid modifications such as myristoylation and palmitoylation. Myristoylation, the irreversible 
attachment of a myristic acid, is vital to membrane localization of the Gα2 subunit, and its 
dysfunction can lead to inadequate cAMP response (Root et al., 1999). Palmitoylation allows for 
a reversible attachment of palmitate to a cysteine via thioester linkage, allowing for enhanced 
hydrophobicity of a substrate protein to localize to the plasma membrane. Palmitoylation is 
also vital to proper localization and function of the Gα2 subunit (S. Alamer et al., 2018). 
 Intracellular S-palmitoylation reactions are catalyzed by a family of DHHC protein 
acyltransferases (PATs) (Greaves & Chamberlain, 2011). DHHC proteins transfer palmitate in a 
two-step process; the enzyme first uses autoacylation to modify itself with palmitate, then it 
transfers the palmitate to the substrate protein (Bahl, 2006; Wells, 2003).. These DHHC PATs all 
contain the DHHC-CRD (Cysteine Rich Domain), a highly conserved 51-amino acid catalytic 
domain. Within the DHHC-CRD, there are typically two CCHC zinc fingers; these have previously 
been demonstrated to bind and coordinate zinc ions for the structural integrity of the DHHC 
protein (Gottlieb et al., 2015). It has also been shown that some of the cysteines in the DHHC-
CRD act as the site of autoacylation during the first step of DHHC mediated palmitoylation. 
Specifically, cysteines involved in the second CCHC zinc finger have been observed to bind 
palmitate (Gottlieb et al., 2015). It has also been shown that mutations of these conserved 
cysteines can introduce issues with palmitoylation activity, likely by disruption of the tertiary 




highly conserved motifs, the DPG and TTxE (TTYE) regions, though their function is still 
unknown (Stix et al., 2020). Most research into the DHHC-CRD proteins has centered on 
enzymatic models, as it is challenging to purify these transmembrane proteins. In this regard, 
the unique developmental lifecycle of the model organism D. discoideum provides a fascinating 
in vivo model.  
 In D. discoideum, 14 genes that contain the DHHC-CRD have been characterized and 
labeled Putative Acyltransferases with Zinc Fingers (gene name: pazA-N, protein name: PAZ1-
14) (Bodwell, 2007). These 14 genes have been analyzed for expression during the D. 
discoideum lifecycle (Bodwell, 2007). The large number of DHHC proteins that exist in D. 
discoideum makes for a challenge in determining which are of the greatest significance. Of 
these 14 PAZ proteins, the PAZ5 protein (pazE gene) is the first to be characterized in greater 
detail. Unlike other PAZ proteins, the PAZ5 protein contained no introns, providing a tantalizing 
opportunity for mutagenic phenotype analyses. Initial work characterizing the PAZ5 protein 
used qRTPCR and phenotypic analysis to determine that it had a high expression level during 
the trophic and culmination stages of development, especially in the formation of stalks 
(Bodwell, 2007).  
Further investigations into PAZ5 determined a significant difference in stalk formation 
when one of two mutations were made to the tetrapeptide DHHC motif itself. Specifically, one 
mutation replaced the first histidine with alanine, and the other mutation involved replacing 
the cysteine with a serine (Amburg, 2010). These mutations disrupted the DHHC region and 




phenotype was identical to cells with the knockout of the PAZ5 protein, suggesting that the 
DHHC motif was essential to the protein's function (Amburg, 2010). 
The phenotype consisted of the fruiting body growing to a third its standard height, then 
collapsing under its own weight, before continuing to grow along the surface of the agar, 
suggesting the stalk had weakened in strength (Amburg, 2010). Calcofluor staining of cellulose 
deposited by the cells revealed deficits in the stalk's structural organization, namely a 
disruption in the cell organization. The lower stalk is typically composed of multiple layers of 
cells for support; in the malformed phenotype, the lower stalk was composed of a single cell 
stack, a feature usually seen only in the upper parts of the stalk (Amburg, 2010). The stalk 
collapses when a larger than normal ball of pre-spore cells travels up the narrow stalk, bending 
it over and causing the spore head to burst upon contact with the agar surface. Though not 
proven, it was hypothesized that this change in cellular structure was due to a change in pre-
stalk ratio to pre-spore cells during the tight aggregate stage of development.  
The occurrence of a clear phenotypic change for the PAZ5-KO line suggests that 
mutation rescue is a viable option to test the significance of the DHHC-CRD conserved sequence 
(Amburg, 2010). To that end, single-base substitutions of conserved residues in the DHHC-CRD, 
DPG, and TTxE residues of the pazE gene will be created. These mutant PAZ5 proteins will then 
be moved into a green fluorescent protein (GFP) fusion/expression vector and transformed into 
D. discoideum with a PAZ5 knockout (Amburg, 2010). The PAZ5 knockout was earlier created in 
the Gundersen lab, but we will remake it and confirm its function too. The resulting 
transformants will then be investigated for their intracellular localization via confocal 




primarily in fruiting body formation. These observations can be grouped with the kind of 
mutation introduced and the effect of the mutation on the phenotype of the organism. The aim 
is to determine the functional importance of the conserved residues in the PAZ5 protein/pazE 
gene using an in vivo model and use this information to determine how the DHHC-CRD family 





MATERIALS AND METHODS 
 
2.1. Cell Culture  
 In this study, an axenically grown AX-2 stock strain of D. discoideum was used as the 
wild-type cell line. The cells were grown under axenic conditions using HL-5 media (1% 
dextrose, 1% neutralized proteose peptone, 0.5% yeast extract, 3.6 mM Na2HPO4, 3.6 mM 
KH2PO4, and 41 μM dihydrostreptomycin; autoclaved then filter sterilized using Nalgene Rapid-
Flow Vacuum Filters) at 22 oC (Watts & Ashworth, 1970). The cells were grown on cell culture 
plates or in a shaking culture. 
 A knockout strain of PAZ5 (PAZ5-KO) was also grown from D. discoideum stock. The 
PAZ5-KO strain was previously created by inserting a 1.4 kb Blasticidin S (BLS) resistance 
cassette into the ClaI site (ATCGAT) of PAZ5, located at 1040 bp (Amburg, 2010). The PAZ5-KO 
strain was also remade recently and re-analyzed for the phenotype observed in the original 
PAZ5-KO strain. The cells were grown on HL-5 cell culture plates with BLS (20 μg/mL, 13 μL BLS 
in 13 mL HL-5) instead of G418 (20 μg/mL, 13 μL BLS in 13 mL HL-5) as the antibiotic selection 
media.  
 
2.2. Polymerase Chain Reactions  
 PCR was used for three kinds of reactions. Firstly, a mutation was made to the 
PAZ5/pGEM (5.5 kb) plasmid was to remove the already-present KpnI site by substituting the 




cDNA had earlier been inserted into a pGEM plasmid (Promega). Secondly, PCR was used to 
generate single base substitutions in the PAZ5 gene to change single highly conserved amino 
acids of the DHHC-CRD in the PAZ5/pGEM-KpnImut plasmid via site-directed mutagenesis 
(Reikofski & Tao, 1992). Lastly, after cloning and recovering the mutant PAZ5/pGEM-KpnImut 
DNA, PCR was used to add a KpnI linker cassette to the ends of the PAZ5 gene in the 
PAZ5/pGEM plasmid for ligation into the pTX-GFP expression vector (Levi et al., 2000).  
For site-directed mutagenesis, complementary primers were designed with a mismatch 
a minimum of 20 bp from the end of the respective primer sequence. As the primers were 
extended, the mutation was created in the resulting amplicon (Kunkel, 1985; Zoller, 1991). 
Seventeen different mutant varieties were created in this manner, each with their specific 
annealing temperatures calculated via the Tm calculator from NEB (NEB Tm Calculator, n.d.). 
They were also checked for hairpin formation via OligoCalc (OligoCalc: Oligonucleotide 
Properties Calculator, n.d.). A total of 17 such mutations were made, labeled 1-17 based on the 
date the original mutant primer was created. The number and corresponding label are shown 
below. 
Originally the Phusion High-Fidelity DNA Polymerase (NEB) was used. However, during 
the research, the switch was made to the Q5 Ultra-High-Fidelity DNA Polymerase (NEB) due to 
its higher fidelity and because it similarly produced blunt ends (Menin, n.d.). 
 





















D475A (4)  
G477Y (1)  
C506A (2)  
C509G (3)  
P514A (8)  
R516P (9)  
H519L (15)  
C523G (6)  
F530S (16)  
W536L (10)  
N538I (11)  
G542S (12)  
Q546L (17)  
F549S (14)  
F549V (13)  
T628A (5)  
E631A (7)  
 
Red indicates a mutation to a conserved amino acid; green are members of the DPG motif; 
purple are members of the first CCHC zinc-finger; blue corresponds to the second CCHC zinc 







Complete Primer Sequences 
 
ID     Sequence     Tm Ta Notes 
G477Ys (1)   AAGGAAGATCCATACACAATTTCTAAACATATCTC   65 66 OK 
 G477Ya  TGTTTAGAAATTGTGTATGGATCTTCCTTTGTTAAACGAATG 69 66 OK 
C506As (2)   ATCCCTTTGATTGCTCCAACCTGTTTAATTAATCG   70 71 OK 
 C506Aa  TTAAACAGGTTGGACGAATCAAAGGGATTTGACGACCAC  75 71 OK 
C509Gs (3)  ATTTGTCCAACCGGTTTAATTAATCGTCCAATTCGTTC  71 72 OK 
 C509Ga  TGGACGATTAATTAAACCGGTTGGACAAATCAAAGGG  72 72 OK 
D475As (4)  TTAACAAAGGAAGCTCCAGGCACAATTTCTAAAC   70 71 OK 
 D475Aa  AGAAATTGTGCCTGGAGCTTCCTTTGTTAAACGAATG  73 71 OK 
T628As  (5)  TTATTCAATAAAGCTACTTATGAACAAATTCAAC   62 63 OK 
 T628Aa  TGTTCATAAGTAGCTTTATTGAATAAAATTGTTAAAACTTGTG 65 63 OK 
C523Gs (6)  CATTGTCCATCTGGTAAAGGTTGTTTTGCACG   71 72 OK 
 C523Ga  TGCAAAACAACCTTTACCAGATGGACAATGTTTTGAACG  73 72 OK 
E631As (7)   AAACTACTTATGCACAAATTCAACAAATTAGAG   63 64 OK 
 E631Aa  ATTTGTTGAATTTGTGCATAAGTAGTTTTATTGAAT  63 64 OK 
P514As (8)   TGTTTAATTAATCGTGCAATTCGTTCAAAACATTGTCC  69 70 OK 
 P514Aa  TGTTTTGAACGAATTGCACGATTAATTAAACAGGTTGG  70 70 OK 
R516Ps (9)   TTAATCGTCCAATTCCTTCAAAACATTGTCCATCCTG  71 68 OK 
 R516Pa   GGACAATGTTTTGAAGGAATTGGACGATTAATTAAAC  67 68 OK 
W536Ls (10)   TCATCATTGTGTTTTGATTAATAAATGTATTGGTATC  63 64 OK 
 W536La  ATACATTTATTAATCAAAACACAATGATGATCAAAACG  64 64 OK 
N538Is (11)  ATTGTGTTTGGATTATTAAATGTATTGGTATCAATAAC  63 64 OK 
 N538Ia    TACCAATACATTTAATAATCCAAACACAATGATGATC  65 64 OK 
G542Ss (12)  TTAATAAATGTATTAGTATCAATAACCAAGCTTTATTC  61 62 OK 
 G542Sa  GCTTGGTTATTGATACTAATACATTTATTAATCCAAAC  64 62 OK 
F549Vs (13)   ATAACCAAGCTTTAGTCATCACTGTACTCTTCTCATATG  69 70 OK 
 F549Va   GAGTACAGTGATGACTAAAGCTTGGTTATTGATACC  69 70 OK 
F549Ss (14)   TAACCAAGCTTTATCCATCACTGTACTCTTCTCATATG  69 70 OK 
 F549Sa   AAGAGTACAGTGATGGATAAAGCTTGGTTATTGATACC  69 70 OK 
H519Ls (15)   CAATTCGTTCAAAACTTTGTCCATCTTGTAAAGGTT  68 69 OK 
 H519La  TACAAGATGGACAAAGTTTTGAACGAATTGGACGAT  70 69 OK 
F530Ss (16)   GTTGTTTTGCACGTTCTGATCATCATTGTGTTTGG   71 72 OK 
 F530Sa   ACACAATGATGATCAGAACGTGCAAAACAACCTTTAC  71 72 OK 
Q546Ls (17)   TTGGTATCAATAACCTAGCTTTATTCATCACTGTAC  67 65 OK 








Partial Primer Sequence  
 
ID     Sequence     Tm Ta Notes 
G477Ys (1)     TACACAATTTCTAAACATATCTC    54 55 OK 
 G477Ya   TATGGATCTTCCTTTGTTAAACGAATG   62 55 OK 
C506As (2)   GCTCCAACCTGTTTAATTAATCG    61 62 OK 
 C506Aa   CGAATCAAAGGGATTTGACGACCAC   68 62 OK 
C509Gs (3)   GGTTTAATTAATCGTCCAATTCGTTC   62 63 OK 
 C509Ga   CGGTTGGACAAATCAAAGGG    64 63 OK 
D475As (4)   CTCCAGGCACAATTTCTAAAC    61 60 OK 
 D475Aa   GCTTCCTTTGTTAAACGAATG    59 60 OK 
T628As (5)   GCTACTTATGAACAAATTCAAC    56 57 OK 
 T628Aa   CTTTATTGAATAAAATTGTTAAAACTTGTG  57 57 OK 
C523Gs (6)    GGTAAAGGTTGTTTTGCACG    62 63 OK 
 C523Ga   CAGATGGACAATGTTTTGAACG    62 63 OK 
E631As (7)    CACAAATTCAACAAATTAGAG    54 53 OK 
 E631Aa   GCATAAGTAGTTTTATTGAAT    52 53 OK 
P514As (8)    GCAATTCGTTCAAAACATTGTCC    63 60 OK 
 P514Aa   CACGATTAATTAAACAGGTTGG    59 60 OK 
R516Ps (9)   CTTCAAAACATTGTCCATCCTG    61 57 OK 
 R516Pa   GGAATTGGACGATTAATTAAAC    56 57 OK 
W536Ls (10)    TGATTAATAAATGTATTGGTATC    52 53 OK 
 W536La    AAAACACAATGATGATCAAAACG   59 53 OK 
N538Is (11)    TTAAATGTATTGGTATCAATAAC    52 53 OK 
 N538Ia      ATAATCCAAACACAATGATGATC    58 53 OK 
G542Ss (12)   AGTATCAATAACCAAGCTTTATTC   57 50 OK 
 G542Sa    TAATACATTTATTAATCCAAAC    49 50 OK 
F549Vs (13)    GTCATCACTGTACTCTTCTCATATG   62 59 OK 
 F549Va    CTAAAGCTTGGTTATTGATACC    58 59 OK 
F549Ss (14)    CCATCACTGTACTCTTCTCATATG   62 59 OK 
 F549Sa    GATAAAGCTTGGTTATTGATACC    58 59 OK 
H519Ls (15)    TTTGTCCATCTTGTAAAGGTT    58 59 OK 
 H519La   AGTTTTGAACGAATTGGACG    60 59 OK 
F530Ss (16)    CTGATCATCATTGTGTTTGG    58 59 OK 
 F530Sa    GAACGTGCAAAACAACCTTTAC    62 59 OK 
Q546Ls (17)    TAGCTTTATTCATCACTGTAC    56 53 OK 








Standard Reaction Conditions: 
10 μL 5X Q5 Reaction Buffer 
1 μL 10 mM dNTPs 
1 μL 20 μM Forward Primer 
1 μL 20 μM Reverse Primer 
1 μL Template DNA (1-10 ng) 
0.5 μL Q5 High-Fidelity DNA Polymerase 
35.5 μL Nuclease-Free Water 
50 μL Total Reaction Volume 
 
As the site-directed mutagenesis primers were only partially aligned for the first cycle, 
the annealing temperature was calculated using only the sequence up to the mutation. 
Therefore, the PCR program involves the first cycle with a lower temperature, and all 
subsequent cycles involve temperature calculated from the whole sequence. For all other PCR 
programs, the first cycle was not included. 
 
Standard Reaction Program: 
98 oC for 30 seconds (Initial Denaturation) 
98 oC for 10 seconds (First Cycle Denaturation) 
52-63 oC for 30 seconds (First Cycle Primer Annealing) 
72 oC for 3 minutes (First Cycle Extension) 




63-72 oC for 30 seconds (Subsequent Cycle Primer Annealing) 
72 oC for 3 minutes (Subsequent Cycle Extension) 
GOTO Step 5, 18 Times (20 Total Cycles) 
72 oC for 6 minutes (Final Extension) 
6 oC for 5 minutes (Hold) 
  
 Initially, the plan was to directly mutate the PAZ5/pTX-GFP expression vector directly 
rather than individually mutate PAZ5 and ligate it into pTX-GFP each time. However, the D. 
discoideum genome - and by extension, the Ddp1 derived backbone of the pTX-GFP expression 
vector - is very AT-rich, with content approaching 80% (Glöckner et al., 2002). The AT content 
may have prevented even Ultra-High-Fidelity polymerases, such as Q5, from remaining 
attached to the DNA strand (Charette & Cosson, 2004; Larsson et al., 2008).  
 
2.3. Restriction Enzyme Digestion  
 After the PCR reaction designed to elicit site-directed mutagenesis, enzyme digests 
using DpnI (New England Biolabs) were performed on the entire PCR product to hydrolyze the 
parental DNA before transformation into chemically competent E. coli DH5α cells. 5 μL 
CutSmart Buffer (New England Biolabs) and 0.5 μL DpnI were added to 50 μL PCR product and 
incubated at 37 oC for 15 minutes, then heat-inactivated at 80 oC for 20 minutes. 2.5 μL of DpnI-
digested PCR product was then run on a gel to validate the size of the PAZ5/pGEM plasmid (5.5 
kb), to determine the degree of unwanted primer dimerization (Chou et al., 1992), and to 




digested PCR product would then be used to transform into chemically competent E. coli DH5α 
cells. 
 After the cloning, recovery, and KpnI linker process, a second restriction enzyme 
digestion was performed. Firstly, the PCR product was purified of its polymerase using a 
Monarch PCR and DNA Cleanup Kit (New England Biolabs) and eluted in 50 μL of elution buffer. 
An enzyme digest was then performed on the total volume using 5 μL CutSmart 10X Buffer, 0.5 
μL DpnI and 0.5 μL KpnI-HF and incubated at 37 oC for 15 minutes. After that, it was purified 
again using a Monarch PCR and DNA Cleanup Kit as KpnI-HF is resistant to heat-inactivation and 
eluted in 20 μL. A gel was then run again to determine the ratio required for a T4 ligation (Kuhn 
& Frank-Kamenetskii, 2005).  
A phenol-chloroform extraction could also be performed in place of the Monarch 
Cleanup Kit (Sambrook & Russell, 2006). This step was the original method for purifying nucleic 
acids in the experiments, but it was superseded due to the time it takes to process large 
quantities of samples. It can also leave traces of chloroform in the final sample that makes use 
of the NanoDrop untenable.  
 Lastly, before ligating the prepped DNA from the earlier step into the pTX-GFP 
expression vector, the vector had to be digested with KpnI-HF and Antarctic Phosphatase (New 
England Biolabs). These were used to cut and dephosphorylate the ends of the DNA to prevent 
religation of the newly linearized plasmid DNA, respectively. The reaction involves 2 μg of 
purified pTX-GFP immersed in 1 μL CutSmart, 2 μL KpnI-HF and nuclease-free water up to 10 μL, 
incubated at 37 oC for 15 minutes. Immediately after, 2 μL of Antarctic Phosphatase buffer, 4 μL 




further 30 minutes. After, the DNA was again purified using a Monarch PCR and DNA Cleanup 
Kit and examined via NanoDrop for concentration (Desjardins & Conklin, 2010). 
 
2.4. Gel Electrophoresis  
 Gel electrophoresis was performed with a 1% agarose gel and 1X TPE (Tris-Phosphate-
EDTA) buffer. The 1kb DNA ladder (NEB) (Figure A.4) was used as a marker at 0.5 μg/lane. Gel 
Loading Dye, Purple (6X), no SDS Ladder (New England Biolabs) was added to each sample, 
including the ladder. After the gels had been run, they were soaked in ethidium bromide (1 
μg/mL) (Sutherland et al., 1984) and scanned at 600 dpi using an Azure Biosystems c300 
Imaging System. 
 
2.5. High-Efficiency Transformation and Cloning into E. coli  
 Cloning into E. coli was utilized at two stages of the experimental process. Firstly, for the 
treated PCR product from the site-directed mutagenesis of the PAZ5/pGEM plasmid. Secondly, 
cloning was used after ligating the KpnI-linker mutated PAZ5/pGEM plasmid and pTX-GFP 
expression vector via the T4 ligation.  
The DH5α cell line of E. coli (New England Biolabs) was used for the transformation and 
cloning procedures. 2.5 μL (10-20 ng) of the digested PCR product was mixed into a tube of NEB 
5-alpha Competent E. coli cells that had been thawed on ice; the mixture was then flicked 5 
times to mix cells and DNA. The mixture was then placed on ice for 30 minutes before being 
heat-shocked at 42 oC for 30 seconds. After being placed on ice for a further 5 minutes, 950 μL 




mM KC1, 10 mM MgCl2, and 20 mM glucose) was added, and the tubes were incubated on a 
shaker at 37 oC for one hour at 250 rpm. Cells were then mixed thoroughly by flicking the tube. 
Finally, 125-200 μL (depending on plate size) of transformed cells were spread onto an LB (1% 
tryptone peptone, 0.5% yeast extract, and 0.17 M NaCl, 1.5% agar) plate that had been spread 
with 40 μL ampicillin (500X stock) 30 minutes prior. The plates were then incubated at 37 oC 
overnight (16-20 hours) (Biolabs, n.d.-a; Inoue et al., 1990). The remaining vial of cells was 
stored at -20 oC for up to 14 days. 
After incubation, 2-4 individual colonies were picked and incubated overnight (16-20 
hours) in 5 mL LB+AMP solution (ampicillin at 100 μg/mL) in a 50 mL conical tube. After this, a 1 
mL fraction of the incubated solution was stored and frozen at -80 oC by suspending it in 
glycerol at a 680:320 μL ratio (Lovelock, 1953). The remaining solution was then processed 
using the QIAprep Spin Miniprep Kit (Qiagen) to extract the sample's plasmid DNA (QIAprep 
Spin Miniprep Kit - QIAGEN Online Shop, n.d.; Sauer et al., 1998). This process involves lysing the 
bacterial cultures by centrifuging the cells at 5000 rpm for 5 minutes, then immediately 
removing the supernatant and adding a series of buffers provided in the kit, labeled in order: 
‘P1, P2, N3, PB and PE’. This procedure acts to bind, wash and elute the lysate such that the 
DNA binds to a silica membrane until all the impurities are washed away, before being eluted in 
a small volume of elution buffer.  
Depending on the application, the eluted DNA could then be further precipitated via the 
ethanol precipitation protocol. Wherein 1/10 of the volume of 3M NaCH3COO and 3 volumes of 
100% ethanol are mixed into the DNA solution and allowed to freeze overnight at -20 oC. After 




before being decanted, washed with 300 μL of 70% ethanol, and dried in a vacuum 
concentrator (Green & Sambrook, 2016). Thereupon it was eluted in 20 μL of elution buffer and 
examined for concentration via a NanoDrop.   
 
2.6. Ligation and Verification of Fusion Protein Expression Vectors  
 The PAZ5 gene had earlier given one of a series of mutations, then had a KpnI linker 
cassette added on both ends via PCR, then been digested using DpnI and KpnI to cut the PAZ5 
gene from the PAZ5/pGEM plasmid, confirmed via gel electrophoresis. The pTX-GFP expression 
vector had been cut with KpnI and dephosphorylated with Antarctic Phosphatase to prevent 
the linearized plasmid DNA from re-ligating on its own. The amount of pTX-GFP recovered was 
also confirmed via gel electrophoresis.  
 Based on the gel electrophoresis results, a T4 ligation reaction was set up using a molar 
ratio of 1:3 vector: insert. The required mass of 37 ng Insert DNA was calculated using the Insert 
DNA length (2.2 kb for PAZ5), the Vector DNA length (11.2 kb for pTX-GFP), and the Vector DNA 
mass (64 ng); calculated using the NEBioCalculator (Biolabs, 2018; NEBioCalculator, n.d.). The 
T4 ligation reaction involved mixing the components and incubating at room temperature for 
20 minutes, then chilling on ice and transforming 2.5 μL into 25 μL NEB DH5α competent cells 
using the protocol stated earlier (Biolabs, n.d.-b; Tabor, 1989). 
 
Standard T4 Ligation Reaction: 
2 μL T4 DNA Ligase Buffer (10X) 




1 μL Insert (PAZ5 Mutant at 0.060 pmol) 
1 μL T4 DNA Ligase 
15 μL Nuclease-Free Water 
 
 The resulting colonies were then screened for the correct ligation outcome via the 
Boiling Miniprep method for rapid small-scale plasmid DNA preparation. This step is necessary 
due to the often-low ligation efficiency provided by the T4 ligation; moreover, there is a 50/50 
chance that the PAZ5 gene will be inserted in the wrong direction in the pTX-GFP plasmid. The 
boiling miniprep process involves partially lysing the cells to allow plasmid molecules to escape 
into the supernatant while leaving genomic DNA within the cell lysate; this was performed by 
centrifuging the cells at 6000 rpm for 5 minutes. Any remaining genomic DNA is removed 
during a lysozyme (10mg) and STET (8g sucrose, 5 mL Triton X-100, 10 mL 0.5 M EDTA, 5 mL 1M 
Tris-Cl at pH 8.0, water) digestion. Then a high-temperature denaturation step was immediately 
followed by rapid annealing via isopropanol. During subsequent ethanol precipitation, any 
remaining genomic DNA is lost while the plasmid DNA reassociates (Harwood, 1996), and the 
plasmid DNA is left in a concentrated form.  
The plasmid DNA was then ready to be examined on a gel, but first, some had to be 
digested using KpnI to cut open the ligated portions of the PAZ5/pTX-GFP vector. The DNA must 
then be treated with ribonuclease to degrade leftover RNA from the sample. If successful 
ligation has occurred, the gel will have two bands, a 2.2 kb band corresponding to PAZ5 and an 
11.2 kb band corresponding to the pTX-GFP plasmid. Upon confirmation of successful ligation 




time using EcoRI. This step was to confirm that the PAZ5 gene had been ligated into the pTX-
GFP vector in the correct orientation (Dooley et al., 1993). Both PAZ5 (Figure A.1) and pTX-GFP 
(Figure A.2) have EcoRI sites such that, if PAZ5 is ligated in the correct orientation, it will have a 
band dropout with a 2.1 kb size; if it is in the wrong orientation, the band will instead be 1.4 kb 
in size. Only sequences with the correct EcoRI band dropout will be transformed into D. 
discoideum. 
 
Standard Boiling Miniprep Digestion Reaction: 
1 μL CutSmart Buffer 
2 μL Plasmid DNA 
1 μL Enzyme (EcoRI or KpnI, diluted 2:8 Enzyme: Buffer) 
6 μL Nuclease-Free Water 
  
 Upon confirmation of successful ligation via KpnI and EcoRI digestions, the original 
colony can be grown up overnight using the E. coli cloning method. The strain could then be 
frozen for further use and processed using a Qiagen Spin Miniprep kit in anticipation of 
sequencing and transformation into D. discoideum.  
 
2.7. Sequencing PAZ5 for Mutation and KpnI Linker Cassette  
 Sequencing was performed at three points. Firstly, to confirm the presence of the base 
substitution that mutated the KpnI site in the wild-type strain of the PAZ5/pGEM from a GTA 




made via the mismatched primer PCRs in the PAZ5/pGEM plasmid. The final use of sequencing 
was after the PAZ5 gene had the KpnI linker cassette placed at either end, then been ligated 
into the PAZ5/pTX-GFP expression vector. This was to confirm both that the KpnI linkers were 
there (also confirmed by cutting PAZ5/pTX-GFP with KpnI and looking for the two dropout 
bands at 2.2 kb and 11.2 kb) and that the 5’ and 3’ ends of PAZ5 were in-frame with the pTX-
GFP plasmid.  
 Sequencing was performed via the Thermo Fisher 3730 DNA Analyzer with the XL 
upgrade (Fisher, 2002). The Sanger sequencer was capable of yielding between 800-1000 bases 
of sequence per primer; hence a total of three primers were used to sequence the 2.2 kb PAZ5 
gene. Outputted sequences were run through the Auto PeakTrace RP Basecaller suite 
(PeakTrace White Paper, n.d.) to improve basecalling reads. They were then formatted in the 5’ 
to 3’ direction, as needed (Reverse Complement, 2020). The formatted sequences were 
manually merged to produce a complete sequence of the PAZ5 gene and provide a sequence 
for the bases up- and down-stream of the PAZ5 insert in the pTX-GFP plasmid. The sequences 
were translated using the online ExPASy tool (ExPASy - Translate Tool, 2020) to determine the 
reading frame they were in and place them in a FASTA format. Finally, the translated read was 
exported to MUSCLE, a multiple sequence alignment tool (MUSCLE < Multiple Sequence 
Alignment, 2020), and compared to the standard PAZ5/pTX-GFP sequence for verification of 







2.8. Transformation of Expression Vector into D. discoideum via Electroporation  
 Transformation of the PAZ5/pTX-GFP expression vector into D. discoideum was 
accomplished using Electroporation (Fey et al., 2007; Knecht & Pang, 1995). The cells to be 
transformed were the PAZ5-KO line, which contained a knockout PAZ5 gene; created by 
inserting a 1.4 kb Blasticidin S (BLS) resistance cassette into the ClaI site of PAZ5. The mutant 
PAZ5/pTX-GFP plasmid would act as a rescue of the PAZ5-KO. The PAZ5-KO cells for 
transformation were grown over 2-3 days in the presence of BLS such that they were still 
growing in the log phase. They were grown to 1-2 x 106 cells/mL (cultures over 4 x 106 cells/mL 
secrete factors that trigger entry into development). Cell counts were performed manually 
using a Metallized Hemacytometer (Metallized Hemacytometer Reichert Bright-Line, n.d.). Each 
transformation required 1 x 107 cells/mL and 5-10 μg of plasmid DNA at a minimum 
concentration of 500 ng/μL. According to the number of transformations, the appropriate 
number of cells were harvested and pelleted at 500 x g for 4 minutes at 4 oC. The pelleted cells 
were then gently washed with 5 mL of ice-cold Electroporation buffer (E buffer) (1 mM NaPO4 
pH 6.3 and 250 mM sucrose) and pelleted again. The pellet was then resuspended in E buffer at 
2 x 107 cells/mL, with each 500 μL corresponding to the number of transformations to be 
performed. 
 Then 5-10 μg of Plasmid DNA in a maximum of 10 μL elution buffer were placed into a 
cold Eppendorf tube with the 500 μL of E buffer mixed cells, then flicked four times and allowed 
to incubate on ice for 5 minutes. 450 μL of the sample mixture was then transferred to a 0.2 cm 
electroporation cuvette and gently pipetted up and down. Electroporation was performed using 




resistance, and 125 μF extended capacitance. A time constant of 0.5-0.6 ms was ideal. The 
samples were then incubated on ice for 10 minutes. The sample was then transferred to a cell 
culture plate with 2 μL of healing solution (100mM CaCl2 and 100 mM MgCl2), swirled gently, 
and incubated at 22 oC for 15 minutes. Then 13 mL of HL-5 media was added. The plate was 
then incubated for 24 hours at 22 oC, thereupon 13 μL of the antibiotic G418 (20 μg/mL in 10 
μM Hepes pH 7.2; 13 μL G418 in 13 mL HL-5) was added for drug selection of the expression 
vector (Pang et al., 1999). 50 μL of heat-killed Klebsiella aerogenes (made from overnight 
culture and killed by heating to 70 oC for 20 minutes) was also added to the sample to promote 
initial growth (Joly et al., 1993). The media was then changed (13 mL HL-5 and 13 μL G418) 
every 72 hours for 14 days, then every week after that, to remove dead cells and encourage 
growth. For the first 14 days, the media is changed with care not to disturb cells adhering to the 
plate itself; after 14 days, the plate is instead rinsed such that the adhered cells are mixed into 
the media to be removed. 
 
2.9. Storing D. discoideum Cell Lines 
 Between 14 and 21 days after the electroporation, freezer stocks were made for long-
term storage. 2 x 107 cells/mL (1 mL per freezer stock vial) were pelleted at 500 x g for 4 
minutes at 4 oC. The pellets were then resuspended in HL-5 containing 25% fetal bovine serum, 
corresponding to half the final total volume. Then HL-5 containing 25% fetal bovine serum and 
40% DMSO were added to bring the cells up to the final volume. Then 1 mL of the cell mixture 
was pipetted into screw cap Eppendorf tubes; these were encased in a Styrofoam block and 




freezer. After 24 hours, the cultures were removed from the Styrofoam block and stored 
indefinitely at -80 oC. 
 
2.10. Photography of D. discoideum Development  
 The D. discoideum cells needed to undergo starvation in order to trigger their fruiting 
body lifecycle. Cell lines to be examined were grown up to a suitable concentration by rinsing 
the media from a plate undergoing log phase and depositing the HL-5 mixed with live-cells into 
a shaking flask containing 100 mL HL-5 and 100 μL G418. After 48-72 hours, the cells would 
have reached a concentration of 1-3 x 106 cells/mL, indicating they are still in their log-phase. 5 
x 107 cells per plate were harvested and pelleted at 500 x g for 4 minutes. They were then 
washed with an equal volume of sterile development buffer (DB) (10 mM NaPO4 pH 6.3, 2 mM 
MgSO4, and 0.2 mM CaCl2). The cells were then re-pelleted and re-suspended in 5 mL of DB (5 
mL per plate). The cells were then added to a sterile DB plate (DB with 1.5% agar) and allowed 
to sit for 5 minutes. The excess DB was then carefully aspirated off, and the plates were allowed 
to dry for 1 minute at room temperature.  
 The plates were then incubated at 22 oC for 48 hours post-starvation (hps). Time-lapse 
studies involved images being taken at 4X magnification every 6 minutes for 48 hours (480 
total). Images began being taken within 15 minutes post-starvation, using an Olympus 
microscope and a SPOT Idea 1.3-megapixel digital microscope camera (SPOTTM Idea 1.3 Mp, 
n.d.). Imaging of the plates took place at 48 hours using an iPhone 8 attached to a Gosky Cell 
Phone Adapter Mount. All images were processed using Fiji ImageJ (Hartig, 2013; Rasband, 




2.11. Confocal Imaging of Fluorescent D. discoideum Cells 
 The D. discoideum cells should have a fluorescent GFP tag thanks to the GFPmut2 coding 
region in the pTX-GFP plasmid. The cells for imaging were collected by rinsing the growth plates 
during their log-phase and placing 1mL of the cell-suspended HL-5 into the wells of a sterile 24-
well black microcavity plate with clear glass bottom and lid. The cells were left to adhere to the 
bottom of the microcavity plate for 15 minutes at 22 oC; then, the media was removed using a 
Pasteur pipette. 1 mL of DB was then gently added to the cells for a minimum of 2 hours; this 
allowed the cells to extrude stores of material that provide low-level autofluorescence during 
confocal imaging (Engel et al., 2006). After a minimum of 2 hours, the DB was gently removed 
and replaced with an equal volume of fresh DB. The microcavity lid had to cover the cells at all 
times of the process to prevent evaporation of the media.  
 Sequential scanning was performed using the Olympus FluoView FV1000 with an 
Olympus IX-81 inverted microscope, and a 30 milliwatt multi-argon laser was used to collect 
images. Either a 20X, 40X, or 100X oil immersion objective lens was used in conjunction with 
Alexa Fluor 488 nm excitation. A negative control cell line was used each time in the form of the 
PAZ5-KO as this lacked the GFP tag; autofluorescence was observed in the PAZ5-KO line and 
adjusted for accordingly. A positive control cell line was also used to calibrate settings for the 
excitation laser, in the form of a PAZ8-GFP line kindly created by Joel Amburg (Amburg, 2010). 







Confocal Settings on Olympus FluoView FV1000 
Alexa Fluor 488 Laser: 488nm, 5%, 500 HV, 1 Gain, 0% Offset 
TD1 Laser: 488nm, 5%, 128 HV, 1 Gain, 0% Offset 
Exposure: 8 μs/pixel 
C.A.: 105 μm 
Lamp: 7.5v 
  
2.12. Statistical Analysis of Mutant Phenotypes versus Wild-Type 
 A minimum of ten random images was taken for each plate at 48 hps. A grid of ten 
squares was superimposed onto the images, and each square was counted for fruiting bodies. 
The fruiting bodies were divided into three categories: Those that had developed growing 
normally (upright) (Labeled ‘1’ in Figure 2.1); those that developed along the agar, including 
those that formed a standard spore head slightly above the surface of the agar (along agar) 
(Labeled ‘2’ in Figure 2.1); and those that had fallen over and contacted the surface of the plate 
breaking open the spore head (fallen) (Labeled ‘3’ in Figure 2.1). These counts were then 





2.13. Rescue of Knockout  
 The wildtype PAZ5/pTX-GFP fusion expression vector would be used to confirm the 
rescue of the knockout. The wild type still contains the KpnI mutation that allowed for ligation 
into the KpnI site of the pTX-GFP plasmid; however, this mutation was designed to interrupt the 
KpnI recognition site without disrupting the in-frame valine. Instead, the wild-type does not 
contain any other mutations in its sequence, such as the substitutions of conserved residues 
typical of the mutant strains. This wild-type PAZ5/pTX-GFP strain would be transformed into 
the KO line and, if all goes to plan, provide a statistical count of fruiting body phenotypes similar 
to the D. discoideum AX2 strain, the original strain lacking a knockout.  
 
Figure 2.1. Analysis of D. discoideum Fruiting Body Development. Pictured is an example of 
fruiting body analysis. Cells were developed for 48 hours post-starvation. Pictured are the 
lower and upper focal planes (A-1 and A-2). The upright fruiting bodies are labeled ‘1’ in picture 
A-2; the fruiting bodies that have developed along the agar and formed a spore head without 
breaking are labeled ‘2’ in picture A-1; the fallen fruiting bodies with intact spore heads are 





2.14. Development on Bacterial Lawn 
 Cells for cloning can also be obtained using a bacterial lawn of Klebsiella aerogenes. The 
K. aerogenes culture is grown overnight at 37 oC, then 200 μL was spread on SM/5 (0.2% 
dextrose, 0.2% bacto-peptone, 0.02% yeast extract, 0.231% KH2PO4, 0.1% K2HPO4, 2% agar) 
plates and incubated overnight at 37 oC (M. Sussman, 1987). D. discoideum cells are then grown 
into the log growth phase at around 1-2 x 106 cells/mL at 22 oC. A 10 μL drop of the cell culture 










3.1. Creation of PAZ5-KO and PAZ5 Mutant Cell Lines 
 
 A variety of mutants were created to determine the significance of the conserved amino 
acids in the PAZ5 protein. In addition, a knockout line of the pazE gene (PAZ5-KO) was 
regenerated. Each amino acid change involved a substitution point mutation that changed an 
individual amino acid without altering other amino acids in its vicinity. The mutations were 
introduced using PCR via site-directed mutagenesis. For each mutation, a pair of 
oligonucleotides (primers) were designed to resemble a portion of the pazE sequence, albeit 
with an error in its sequence, the error allowing for a different codon sequence. The primers 
would introduce this mutation into the PAZ5/pGEM plasmid, and PCR would amplify its 
presence relative to the parent plasmid. The parent template would then be removed using 
DpnI, methylation-dependent endonuclease, then transformed into E. coli. The PCR product to 
be transformed into bacteria was also run on a gel to confirm that the PAZ/pGEM plasmid was 
still of the same size and to evaluate the efficiency of the PCR by looking for evidence of primer-
dimer (Figure 3.1). A total of seventeen mutations were created in this manner (Table 3.1, 
Appendix B). Of these seventeen, two were created in the DPG and TTYE motifs, four were 
made to the CHHC zinc-fingers directly flanking the DHHC motif, and nine were made to 
conserved non-cysteine amino acids in the DHHC-CRD (Table 3.1). The type of mutation 
introduced varied depending on their purpose. Some were designed to elicit a substantial 




Table 3.1. Amino Acid Substitutions for All Mutants. The amino acid substitutions for all 
mutations are outlined in this table. The type of amino acid change is specified, as is the region 
in PAZ5 (DPG, TTYE, zinc fingers, or DHHC-CRD); the change in molecular weight; and the 
changes to the side chain (polarity and group). Red indicates a mutation to a conserved amino 
acid; purple are members of the first CCHC zinc-finger; blue corresponds to the second CCHC 
zinc finger; and teal are members of the TTYE motif. 
 
Figure 3.1. Mutation Creation in PAZ5/pGEM using PCR. Mutations were made on the 
PAZ5/pGEM (5.2 kb) vector (1-2). The efficiency of the PCR was evaluated by examining the 
formation of primer dimers. These mutations could later be excised and inserted into the pTX-
GFP vector for expression in D. discoideum. A 1kb ladder (NEB) provides a reference (A). 
 
Confirmation that the mutation had been created and that no errant mutations had 
accidentally been created was performed using Sanger sequencing. Plasmid DNA was obtained 
by lysing and prepping plasmid DNA from an E. coli clone. Sanger sequencing produced reads 
Name Original Amino Acid New Amino Acid PAZ5 Region MW Change (g/mol) Chemistry Change
G477Y (1) Glycine (GGC) Tyrosine (TAC) DPG Motif 75 to 181 Non-Polar+Aliphatic --> Polar+Aromatic
C506A (2) Cysteine (TGT) Alanine (GCT) 1st Zinc Finger 121 to 89 Non-Polar+Sulfur-Containing --> Non-Polar+Aliphatic
C509G (3) Cysteine (TGT) Glycine (GGT) 1st Zinc Finger 121 to 75 Non-Polar+Sulfur-Containing --> Non-Polar+Aliphatic
D475A(4) Aspartic acid (GAT) Alanine (GCT) DPG Motif 133 to 89 Negatively-Charged+Acidic --> Non-Polar+Aliphatic
T628A (5) Threonine (ACT) Alanine (GCT) TTYE Motif 119 to 89 Polar+Hydroxylic --> Non-Polar+Aliphatic
C523G (6) Cysteine (TGT) Glycine (GGT) 2nd Zinc Finger 121 to 75 Non-Polar+Sulfur-Containing --> Non-Polar+Aliphatic
E631A (7) Glutamic acid (GAA) Alanine (GCA) TTYE Motif 147 to 89 Negatively-Charged+Acidic --> Non-Polar+Aliphatic
P514A (8) Proline (CCA) Alanine (GCA) DHHC-CRD 115 to 89 Non-Polar+Aliphatic --> Non-Polar+Aliphatic
R516P (9) Arginine (CGT) Proline (CCT) DHHC-CRD 174 to 115 Positively-Charged+Basic --> Non-Polar+Aliphatic
W536L (10) Tryptophan (TGG) Leucine (TTG) DHHC-CRD 204 to 131 Non-Polar+Aromatic --> Non-Polar+Aliphatic
N538I (11) Asparagine (AAT) Isoleucine (ATT) DHHC-CRD 132 to 131 Polar+Amidic --> Non-Polar+Aliphatic
G542S (12) Glycine (GGT) Serine (AGT) DHHC-CRD 75 to 105 Non-Polar+Aliphatic --> Polar+Hydroxylic
F549V (13) Phenylalanine (TTC) Valine (GTC) DHHC-CRD 165 to 117 Non-Polar+Aromatic --> Non-Polar+Aliphatic
F549S (14) Phenylalanine (TTC) Serine (TCC) DHHC-CRD 165 to 105 Non-Polar+Aromatic --> Polar+Hydroxylic
H519L (15) Histidine (CAT) Leucine (CTT) 1st Zinc Finger 155 to 131 Positively-Charged+Basic --> Non-Polar+Aliphatic
F530S (16) Phenylalanine (TTT) Serine (TCT) DHHC-CRD 165 to 105 Non-Polar+Aromatic  --> Polar+Hydroxylic




between 800-1000 bp, so three primers were designed at intervals of 800 bp for the reads to 
start at. The three reads were then compiled into a single string. The string was examined for 
reading frame consistency and compared to a wildtype sequence to confirm that only the 
intended mutation was created. An example of this comparison is pictured for the G477Y PAZ5 
mutant (Figure 3.2). Upon confirmation of success, mutations would then be ligated into a pTX-
GFP plasmid expression vector using a KpnI (GGTACC) site.  
 
Figure 3.2. Example of Wildtype and Mutant Sequence Comparison. Example of sequence 
comparison between the original wildtype sequence (ACT) (figure A) and the PAZ5 mutant 






Before ligating into pTX-GFP could happen, a naturally present KpnI site within PAZ5 first 
had to be removed. So that digesting PAZ5/pGEM with KpnI would only cleave PAZ5 from 
pGEM, rather than cleaving PAZ5 itself. Two primers were created to mutate the KpnI site 
without changing the amino acid composition of what was essentially the wildtype. The original 
valine (GTA) was changed to an alternate valine (GTT); hence the KpnI site (GGTACC) naturally 
present within PAZ5 was changed to GGTTCC and was no longer digestible with the KpnI 
restriction enzyme. This was confirmed via digestion of PAZ5 with the KpnI restriction enzyme 
(Figure 3.3). 
Figure 3.3. PAZ5 Before and After Removal of KpnI Site. The PAZ5 protein already contained a 
KpnI restriction site, in addition to the KpnI cassette added to the ends to be used for ligation. 
The existing KpnI site (rows 3 & 4), when digested with a KpnI restriction enzyme, produces two 
fragments, at 1 kb and 1.25 kb, corresponding to the total length of PAZ5, at 2256 bp. PAZ5 was 
then mutated via PCR to remove the KpnI site (rows 1 & 2). The original valine (GTA) was 
changed to a new valine (GTT); hence the KpnI site (GGTACC) naturally present within PAZ5 was 
no longer digestible with the KpnI restriction enzyme. A 1kb ladder (NEB) provides a reference 
(A & B). 
 
The PAZ5-KO line was created by inserting a 1.4 kb Blasticidin S (BLS) resistance cassette 




two purposes, to disrupt the coding sequence of PAZ5 and provide BLS resistance for antibiotic 
selection. Several clones were picked from the resulting transformation. The presence of the 
BLS cassette within the PAZ5-KO lines was confirmed via PCR of genomic DNA. The wildtype 
PAZ5 was 2.2 kb, and the BLS cassette was 1.4 kb in size. Using a combination of primers, it was 
possible to examine the fragments of PAZ5-KO to determine whether both sequences were 
present (Figure 3.4). The point mutations of PAZ5 contained within the pTX-GFP expression 
vector were later transformed into cells of the PAZ5-KO D. discoideum strain to act as a mutant 
rescue.   
Figure 3.4. Confirmation of PAZ5-KO BLS Insertion. The PAZ5-KO strain contains a 1.4 kb BLS 
cassette inserted at the ClaI (ATCGAT) site of the PAZ5 sequence. PAZ5-KO is 3.6 kb as PAZ5 is 
originally 2.2 kb in length. Two clones were analyzed for correct BLS insertion; these were 
labeled PAZ5-KO (1) and (2). A PCR of the genomic DNA for PAZ5-KO was used to confirm the 
presence of the BLS insertion. PCR from both ends of PAZ5-KO (ATG to STOP codons) should 
present a 3.6 kb band. PAZ5-KO (1) (row 1) produced a 3.6 kb band indicating the BLS cassette 
presence. PAZ5-KO (2) (row 2) produced a 2.2 kb band, indicating it possessed a wild type 
sequence and did not contain the BLS cassette. A 1kb ladder (NEB) provides a reference (A & B). 






3.2. Creation of PAZ5/pTX-GFP Fusion Expression Vector 
 Successful PAZ5 protein mutants in the PAZ5/pGEM vector were ligated into the pTX-
GFP plasmid. The pTX-GFP plasmid expression vector was used due to its potential to provide 
uniform cell-to-cell expression and because it encodes a green fluorescent protein (GFP) on the 
C-termini of a KpnI multi cloning site for sequence ligations. The plasmid contains several useful 
domains conducive to the expression of the mutated PAZ5 protein in D. discoideum. The Ddp1 
backbone, allowing the plasmid to replicate autonomously in D. discoideum (Levi et al., 2000; 
Noegel et al., 1985). The GFP fusion cassette was derived from pGFPmut2, a 20-30 times 
brighter variant than the wildtype GFP. Lastly, pTX-GFP has a Geneticin (G418)-resistance 
cassette, an antibiotic used to inhibit prokaryotes and eukaryotes, allowing for antibiotic 
selection of the successful transformants. 
  After sequencing the individual mutations, the PAZ/pGEM plasmid DNA was then 
modified by adding a KpnI linker cassette (GGTACC) to the ends of the PAZ5 protein. This 
cassette allowed for the PAZ5 to be excised from the pGEM plasmid and make it able to be 
inserted into the KpnI site in pTX-GFP (Figure 3.5). Insertion was accomplished using PCR and 
two primers designed to add the small insertions. DpnI was used to remove the parental 
template DNA, after which the plasmid was immediately cleaved using the KpnI restriction 
enzyme. The presence of the newly introduced KpnI site was confirmed by running a gel of the 




Figure 3.5. Successful Ligation of PAZ5 into pTX/GFP Expression Vector. PAZ5/pazE was ligated 
into pTX-GFP using the KpnI restriction site (GGTACC). The 5’ end of PAZ5 and the 3’ end of the pTX-GFP 
construct are shown (figure A). The 3’ end of PAZ5 and the 5’ end of the pTX-GFP construct are also 
shown (figure B); the TAG/STOP codon of PAZ5 has been removed. The first and last nucleobases 
represented in the image make up the KpnI site (GGTACC). 
 
 The T4 ligase catalyzes the insertion of PAZ5 mutants into pTX-GFP; however, the 
direction that the strands will align in is up to chance. The resulting ligated material was then 




method was used to rapidly prepare the plasmid DNA for digestion with either the KpnI or 
EcoRI restriction enzymes. The purpose of KpnI digestion was to determine whether the ligation 
had successfully taken place. If it had, the 11.2 kb pTX-GFP and 2.2 kb PAZ5 protein would be 
cleaved from one another with the KpnI enzyme, resulting in two distinct bands indicating the 
respective protein (Figure 3.6). The purpose of the EcoRI digestion was to determine the 
orientation of the PAZ5 protein ligated into pTX-GFP. There are a total of three EcoRI sites in 
the PAZ5/pTX-GFP fusion plasmid, of which one is located 719 bp into PAZ5 from the 5’ end. It 
was determined that if the PAZ5 had ligated in the correct direction, it would form an EcoRI RE 
band of ~2100 bp and, if it were in the wrong direction, would generate a ~1400 bp EcoRI RE 
product (Figure 3.7).  
Clones confirmed with this method were then sequenced to confirm that the ligation 
between PAZ5 and pTX-GFP was in-frame and to doubly confirm that the correct mutation was 
present for each (Appendix C). This was confirmed for 16 of the 17 clones, with the exception of 
F549S, which was not remade as a different mutation to the same phenylalanine was used 











Figure 3.6. Clonal Selection via KpnI Digestion for Two PAZ5/pTX-GFP Ligations. Two PAZ5 
mutants were cut out from PAZ5/pGEM, and T4 ligated into pTX-GFP. Eight clones of each 
mutant were then processed using the boiling miniprep method and were digested with the 
KpnI restriction enzyme (1a-h & 2a-h). Successful ligations have bands at 2.2 kb and 11.2 kb, 
respectively, corresponding to PAZ5 and pTX-GFP. Successful ligations were 1adfg & 2abcefgh. 
A 1kb ladder (NEB) provides a reference (A). 
 
Figure 3.7. Clonal Orientation Test via EcoRI Digestion for Two PAZ5/pTX-GFP Ligations. The 
previous ligations from Figure 3. They were further digested with EcoRI to determine the 
orientation of PAZ5 as it ligated into pTX-GFP. Regardless of correct orientation, both would 
have bands at 6 kb and 4 kb. Ligations in the correct orientation will have bands at 2.1 kb; those 
with the incorrect orientation will have bands at 1.4 kb. Those with correct orientations include 





 Upon confirmation of successful PAZ5/pTX-GFP ligation, the plasmid was then moved 
into the D. discoideum PAZ5-KO cell line. The plasmid DNA was transformed using the process 
of electroporation. Electroporation allowed for the introduction of macromolecules, such as 
plasmid DNA, directly into live cells by discharging an electric field into the cell media. The cell 
membrane pores are briefly forced open, permitting the molecules to transit through the 
plasma membrane into the cell to recombine with the cell line. The cells were then be selected 
for and challenged with the antibiotic G418, as the PAZ5/pTX-GFP fusion protein has a G418-
resistance cassette. Growth in the presence of G418, in tandem with the presence of 
fluorescence, was one of the methods of confirming that successful transformation of the PAZ5 
/pTX-GFP mutants had occurred. The process from electroporation to cloning and usage of the 
mutant cell lines took up to 21 days. However, due to several difficulties with transformation 
efficiency, only six of the seventeen mutations were successfully ligated into the D. discoideum. 
Of these six, only four were able to grow in shaking culture. However, all mutants successfully 
transformed into D. discoideum were able to grow in HL-5 media enriched with the G418 
antibiotic. 
 
3.3. Localization of Fluorescence for GFP-Tagged Cells 
 The resultant PAZ5/pTX-GFP transformations were then analyzed for fluorescence, both 
to confirm that the GFP cassette in the pTX-GFP plasmid was functional; and to study where the 
mutated PAZ5 protein would localize. This work was attempted with all successful 
transformants. In addition, as negative fluorescence controls, the PAZ5-KO and wildtype (AX2) 




that had previously shown fluorescence in previous years were also used as positive 
fluorescence controls; these were PAZ8-GFP (PAZ8/pTX-GFP) and pCV5-YFP. PAZ8-GFP was 
grown from a frozen D. discoideum stock; PAZ8 had been ligated into the pTX-GFP plasmid in 
2009 (Amburg, 2010). PAZ8-GFP was to determine if the fluorescence settings used for 
examining the mutant strains would produce a fluorescent signal. pCV5-YFP was created in 
2018 for viewing localization and function of the Gα2 subunit of the G protein (S. A. Alamer, 
2018). pCV5 used an eYFP construct cloned into the CV5 vector. It was grown from an E. coli 
stock and electroporated into the PAZ5-KO strain. This was to determine if the electroporation 
process was causing the loss of fluorescence. 
 None of the successful PAZ5/pTX-GFP transformants showed any signs of fluorescence 
above background- or cell-autofluorescence. The cells of D. discoideum will autofluoresce if 
immediately examined after growth in the axenic HL-5 growth media. However, placing them in 
development buffer (DB) helps to reduce their autofluorescence. This is most obvious with 





Figure 3.8. Epifluorescence Imaging of PAZ5-KO Cells. Confocal epifluorescence imaging of the 
PAZ5-KO cell line, which lacks the GFP cassette present in the PAZ5/pTX-GFP fusion vector, 
indicating autofluorescence. Using the 40x objective and SAP-GFP mirror on the Olympus 
FluoView FV1000. The image was captured by pointing a camera at the microscope lens itself.   
 
 Imaging of the PAZ5/pTX-GFP cells was accomplished using confocal imaging. The laser 
intensity threshold had to be set relatively low, not to bleach the cell and avoid viewing the 
background or cell autofluorescence (settings in Chapter 2.13). When initially viewing the cells, 
a confusing aspect was the occasional presence of bright ‘fuzzy’ cells, which did not have the 
kind of fluorescent signal expected. The fluorescence was not localizing anywhere, but neither 
did it have mislocalized cytoplasmic fluorescence typical of a construct error. Instead, the 
artifacts have a ‘fuzzy’ kind of fluorescent signal; moreover, these artifacts always appeared in 
clusters. These artifacts only appear at higher laser powers, and they appear across multiple cell 
lines, including PAZ5-KO, which lacks any GFP insertions (Figure 3.9).  
The artifacts ceased to appear after sufficiently lowering the laser voltage; this was 




adjusted settings with lower voltages and noting no fluorescence (Figure 3.10). However, at 
these settings, no fluorescence was seen for any of the PAZ5/pTX-GFP cell lines either (Figure 
3.11). This was after the PAZ5/pTX-GFP cell lines had been grown up in G418 antibiotic enriched 
media, which suggested that the G418 resistance marker in pTX-GFP had worked. Hence, the 
use of two cell lines that had previously shown fluorescence, PAZ8-GFP (Figure 3.12) and pCV5-
YFP (Figure 3.13), were used as positive controls. Both positive controls exhibited notable 
fluorescence at the useful settings. PAZ8-GFP localized to the endoplasmic reticulum, and pCV5-
YFP localized to the endoplasmic reticulum and plasma membrane. This observation also 
suggests that Gα2 (product of pCV5-YFP) is not palmitoylated by PAZ5 as it still appears bound to 
the plasma membrane (Figure 3.13).  In combination, the results suggest that the settings are 
not to blame for lack of fluorescence, nor is the transformation process. As the loss of 
fluorescence only appears in the PAZ5/pTX-GFP constructs, it may be that the pTX-GFP plasmid 




Figure 3.9. Fluorescent Artifacts Appear with Higher Laser Voltage Regardless of Cell Line. 
Fluorescent artifacts appear across multiple cell lines if the laser voltage is too high. The 
fluorescence does not localize to any specific area in the cell; instead, it appears ‘fuzzy.’ These 
fuzzy cells always appeared in clusters and were more likely to be found nearer the edge of the 
wells on the 24-well plate. Pictured in order (A-D) are PAZ5-KO, T628A (5), R516P (9), and 
Q546L (17). Captured using a 20x objective and Alexafluor 488 on the Olympus FluoView 











Figure 3.10. Fluorescent Negative Controls. Pictured here are the two negative fluorescent 
controls, PAZ5-KO and wildtype (AX2), corresponding to A and B. These were viewed under the 
same fluorescent laser conditions that elicited fluorescence in the positive controls. The 
transmitted detector laser setting was adjusted between image sets, accounting for the change 
in grey color. Captured using a 40x objective and Alexafluor 488 on the Olympus FluoView 
FV1000.    
 
Figure 3.11. Example of PAZ5/pTX-GFP Mutants Lacking Fluorescence. Pictured here are two 
mutant PAZ5 proteins ligated into pTX-GFP; neither fluoresce when exposed to laser light at the 
correct voltage to avoid artifact formation. Pictured in order (A & B) are T628A (5) and Q546L 






Figure 3.12. Fluorescent Localization for Positive Control PAZ8-GFP (PAZ8/pTX-GFP). Pictured 
is the positive control PAZ8-GFP, which was designed a decade ago to determine PAZ8 
localization in D. discoideum. It was ligated into the same plasmid, pTX-GFP, as PAZ5/pTX-GFP. 
Fluorescence was seen to localize to the endoplasmic reticulum, though this was not confirmed 
with an ER stain. Captured using 40x (A) and 100x (B-E) objectives and Alexafluor 488 on the 







Figure 3.13. Fluorescent Localization for Positive Control pCV5-YFP. Pictured is the positive 
control pCV5-YFP, which was designed to localize the Gα2 subunit in D. discoideum (S. A. Alamer, 
2018). This plasmid was grown from an E. coli stock and transformed into PAZ5-KO in the same 
way as the mutants were with PAZ5/pTX-GFP. Fluorescence was seen to localize to the 
endoplasmic reticulum and plasma membrane. Captured using the 100x objective and 
Alexafluor 488 on the Olympus FluoView FV1000.    
 
3.4. Characterizing the Developmental Phenotypes of D. discoideum Strains 
 Analysis of developing cells was performed 48 hours post-starvation (hps). D. 
discoideum cells were starved on a development buffer (DB) plate after having been subjected 




developmental cycle. Images were captured using a light microscope with camera attachment 
at 48 hps. For movies, images were taken every 6 minutes for 48 hours.  
 Figures 3.14-3.19 show the six strains that were able to grow in shaking culture after 
induction into the starvation phase. Figures 3.20-3.24 show developmental time-lapses for five 
of the six strains (AX2, PAZ5-KO, T628A, C523G, H519L). Fifty million cells were spread on each 
plate for 48 hours-post-starvation (hps). Photographs labeled (A-1, A-2, B-1, etc.) show two 
planes of focus for an individual plate so that the ‘upright’ fruiting bodies can be differentiated 
from the ‘fallen’ or ‘along agar.’ This is because the fruiting bodies can reach up to 2 mm in 
height, those that are out of focus are standing tall, and those on the same plane of focus are 
lying down. Photographs labeled (A, B, C, D, etc.) do not have any visible fruiting bodies that are 
upright; hence the second plane of focus is not provided. 
 The wildtype strain, AX2, was used as a control as it had an intact PAZ5 sequence 
(Figures 3.14 and 3.20). In contrast, the PAZ5-KO strain had an interrupted PAZ5 sequence, 
thanks to the BLS insert at an internal ClaI site of PAZ5 (Figures 3.15 and 3.21). The four 
mutants that grew in shaking culture had an individual mutation of a conserved amino acid in 
the PAZ5 protein (Figures 3.16-3.19 and 3.22-3.24). All observations were made under the same 
conditions (Chapter 2.12). At around 5 hps, both the wildtype and PAZ5-KO strains began to 
form streams of cells as they aggregated together. Aggregation for PAZ5-KO finished by 7 hps, 
forming small to medium aggregates and leaving few cells on their own. Wildtype aggregation 
was finished by 9 hps, with mounds combining to form more massive mounds; the aggregate 
colonies tended to be medium to large. Moreover, the wildtype had far more individual cells 




As slugs, the PAZ5-KO strain did not move after aggregation was completed; the cells 
stayed in place until 17 hours post-starvation (hps), after which they began the process of 
culmination. In contrast, some wildtype aggregates formed into motile slugs at 13 hps and 
began moving around, whereas other aggregates immediately began the culmination process 
(Figures 3.20 and 3.21). By 24 hps, a few wildtype mounds had formed fruiting bodies; more 
aggregates continued to form fruiting bodies up to 35 hps. This was because some slugs kept 
moving until 30 hps, or they collided with a smaller aggregate and immediately began 
culmination. The medium to smaller-sized mounds for the wildtype did not begin culminating, 
but by 40 hps, they had begun moving around, though not to the extent of more massive motile 
slugs, however by 48 hps, they still had not begun culminating. Some fruiting bodies collapsed 
between 36 to 48 hps, though the majority stayed upright. For PAZ5-KO, culmination did not 
take place until 24 hps; only the largest mounds culminated. As mentioned earlier, the vast 
majority of PAZ5-KO mounds were small to medium in size. After 24 hps, no further mounds 
culminated, and PAZ5-KO also produced fewer fruiting bodies than the wildtype (Figures 3.20 
and 3.21). 
 As the mutant strains in the PAZ5/pTX-GFP fusion vector failed to exhibit fluorescence 
associated with the GFP cassette, the plasmid has likely had a function loss. However, it is 
unknown what this loss of function has affected. Hence, any results I interpret from the 
developmental cycle cannot be confirmed as a direct result of the mutations introduced: 
 For the mutant T628A (5), a conserved threonine located in the TTYE motif at 628 aa 
was substituted for an alanine (Figures 3.16 and 3.22). After the start of starvation, it took 9 




10.5 hps, but then the aggregates broke apart again at 16 hps. At 24 hps, the cells began to 
form streams once again, forming a larger number of medium-sized aggregates. However, by 28 
hps, these medium-sized aggregates broke apart and began moving around the agar surface. 
Occasionally some would collide with each other, but the cells did not start the developmental 
stage no matter how much time passed or how large the aggregates became. A few cells were 
left outside of mounds; these tended to be either cells that never aggregated, cells that were 
left behind when the aggregates broke apart at 16 hps, or cells that were not encroached upon 
by aggregates moving around. By 48 hps, no cells had passed beyond the tight aggregate 
(mound) phase. 
 For the mutant C253G (6), a conserved cysteine in the DHHC-CRD at 253 aa was 
substituted for a glycine (Figures 3.17 and 3.23). After the start of starvation, it took 7 hours 
post-starvation (hps) for the cells to begin aggregating. By 9 hps, the cells had formed several 
small aggregates; however, at 14 hps, all the aggregates on the plate broke apart again and 
formed into loose streams of cells mimicking their appearance before 7 hps. The cells then 
remained spread out like they were at the very start of starvation until 24 hps when the cells 
began forming streams of cells once more. Nevertheless, by 29 hps, the cells had once more 
broken apart from the aggregate; from then until 48 hps, a few intermittent streams of cells 
were observed, with the occasional mound-forming, but by and large, it was mostly individual 
cells spread out.  
For the mutant R516P (9), a conserved arginine in the DHHC-CRD at 516 aa was 
substituted for a proline (Figure 3.18). By 48 hours post-starvation (hps), the cells were mostly 




very diminutive in size, but they were upright for the most part. A video was not taken for 
R516P due to time constraints. 
 For the mutant H519L (15), a conserved histidine in the first CCHC zinc finger in the 
DHHC-CRD at 519 aa was substituted for a leucine (Figures 3.19 and 3.24). After the start of 
starvation, it took 6 hours post-starvation (hps) for the cells to begin aggregating. By 8 hps, 
several medium-sized aggregates had formed; however, there were quite a few cells that did 
not aggregate. The mounds did not move after 8 hps, but by 21 hps, the mounds had begun to 
shrink in size, perhaps forming Mexican hats as they culminated; a minimal number of these 
formed into small fruiting bodies, much smaller than the typical height. At 29 hps, a few 
aggregates broke apart, then reformed by 31 hps. This phenomenon happened again at 37 hps, 
where they again reformed at 39 hps. By 48 hps, a slim number of tiny fruiting bodies were 
standing upright; however, the vast majority of mounds were small and had not culminated. 
These results suggest that, barring R516P, the PAZ5 mutants produced phenotypes dissimilar to 
both the knockout and wildtype strains. Moreover, the knockout strain produced a phenotype 
with more fallen fruiting bodies than the wildtype, suggesting that the knockout produced the 
same effect seen before (Amburg, 2010).Taken together three of the four lines examined 
(T628A, C523G, H519L) showed radical departures from both the wildtype and knockout 
strains; whereas the R516P strain was very similar to the wildtype, albeit producing very small 
fruiting bodies.  
Statistical analysis of the different fruiting body phenotypes is presented in Tables 3.1 
and 3.2. The fruiting bodies were divided into three categories: Those that had developed 




breaking open the spore head (fallen); and those that developed along the agar, including those 
that formed a normal spore head slightly above the surface of the agar (along agar). Counts 
were performed at 48 hps across all plates and displayed as a percentage figure. As some plates 
exclusively produced mounds and others produced an overwhelming number of mounds 
compared to the other phenotypes, the two types of data were split into different tables. Table 
3.2 shows the total count of phenotypes, including mounds. Table 3.3 shows the previous 






Cell Line % Upright % Fallen % Along Agar % Mound 
Wildtype 35 (+/- 3) 12 (+/- 2) 7 (+/- 1) 44 (+/- 4) 
PAZ5-KO 11 (+/- 4) 9 (+/- 3) 11 (+/- 4) 66. (+/- 14) 
T628A (5) 0 (+/- 0) 0 (+/- 0) 0 (+/- 0) 100 (+/- 0) 
C523G (6) 0 (+/- 0) 0 (+/- 0) 0 (+/- 0) 100 (+/- 0) 
R516P (9) 33 (+/- 3) 8 (+/- 1) 9 (+/- 1) 49 (+/- 4) 
H519L (15) 9 (+/- 2) 1 (+/- 0) 0 (+/- 0) 87 (+/- 9) 
Table 3.2. Statistical Analysis of PAZ5 Phenotypes with Mounds Included. Plates were 
developed and counted as described. Clones of different cell lines were counted and compared 
to each other. The clones presented are wildtype (AX2), PAZ5-KO (knockout), and the four 
mutants that were able to grow in shaking culture (T628A, C523G, R516P, H519L). Red indicates 
a mutation to a conserved amino acid; purple are members of the first CCHC zinc finger; blue 




Cell Line % Upright % Fallen % Along Agar 
Wildtype 64 (+/- 3) 22 (+/- 2) 13 (+/- 1) 
PAZ5-KO 34 (+/- 4) 30 (+/- 3) 35 (+/- 4) 
T628A (5) 0 (+/- 0) 0 (+/- 0) 0 (+/- 0) 
C523G (6) 0 (+/- 0) 0 (+/- 0) 0 (+/- 0) 
R516P (9) 65 (+/- 3) 16 (+/- 1) 17 (+/- 1) 
H519L (15) 81 (+/- 2) 13 (+/- 0) 5 (+/- 0) 
Table 3.3. Statistical Analysis of PAZ5 Phenotypes with Mounds Excluded. Plates were 
developed and counted as described. Clones of different cell lines were counted and compared 
to each other. The clones presented are wildtype (AX2), PAZ5-KO (knockout), and the four 
mutants that were able to grow in shaking culture (T628A, C523G, R516P, H519L). Red indicates 
a mutation to a conserved amino acid; purple are members of the first CCHC zinc finger; blue 





Figure 3.14. Development of Wildtype (AX2) Cells at 48 HPS Across Two Focal Planes. Cells 
were developed for 48 hours post-starvation. Each letter corresponds to an individual plate. 
Images ending in a number (-1, -2) correspond to two focal planes of the same plate to visualize 
whether cells are upright or have fallen to the agar surface. The wildtype cells mostly form 
upright fruiting bodies, though some fall over, and some mounds fail to differentiate. Captured 




Figure 3.15. Development of PAZ5-KO (Knockout) Cells at 48 HPS Across Two Focal Planes. 
Cells were developed for 48 hours post-starvation and imaged as described. Each letter 
corresponds to an individual plate. Images ending in a number (-1, -2) correspond to two focal 
planes of the same plate to visualize whether cells are upright or have fallen to the agar 
surface. The PAZ5-KO cells tend not to differentiate from the mound stage. Those that do are 
more likely to collapse and grow along the agar; however, some grow upright, similar to the 





Figure 3.16. Development of T628A (5) Cells at 48 HPS Across One Focal Plane. Cells were 
developed for 48 hours post-starvation and imaged as described. Each letter corresponds to an 
individual plate. For T628A, a conserved threonine located in the TTYE motif was substituted for 
an alanine. These cells were unable to differentiate past the mound stage; none could form 





Figure 3.17. Development of C523G (6) Cells at 48 HPS Across One Focal Plane. Cells were 
developed for 48 hours post-starvation and imaged as described. Each letter corresponds to an 
individual plate. For C523G, a conserved cysteine located in the second CCHC zinc finger was 
substituted for a glycine. These cells showed different morphologies on different days; 
however, the cells could not differentiate past the mound stage in general. Sometimes the cells 
would not aggregate at all, resulting in fewer mounds than for other strains. Captured using a 




Figure 3.18. Development of R516P (9) Cells at 48 HPS Across Two Focal Planes. Cells were 
developed for 48 hours post-starvation and imaged as described. Each letter corresponds to an 
individual plate. Images ending in a number (-1, -2) correspond to two focal planes of the same 
plate to visualize whether cells are upright or have fallen to the agar surface. For R516P, a 
conserved arginine in the DHHC-CRD was substituted for a proline. The cells tended to produce 
upright fruiting bodies; however, they were much smaller than those of the wild-type or PAZ5-
KO strains. The focal plane adjustment is needed to visualize them far finer than on other 





Figure 3.19. Development of H519L (15) Cells at 48 HPS Across Two Focal Planes. Cells were 
developed for 48 hours post-starvation and imaged as described. Each letter corresponds to an 
individual plate. Images ending in a number (-1, -2) correspond to two focal planes of the same 
plate to visualize whether cells are upright or have fallen to the agar surface. For H519L, a 
conserved histidine in the first CCHC zinc finger in the DHHC-CRD was substituted for a leucine. 
Very few of the mounds differentiated into fruiting bodies; however, those that did were 
mostly upright. Like R5196P, the fruiting bodies were very diminutive in size compared to AX2 





Figure 3.20. Development of Wildtype (AX2) Strain from 0 to 36 HPS. Cells were developed for 
36 HPS. Images were captured using a 4X objective on an Olympus light microscope with a SPOT 
camera attachment. Color differences between this and other strains were due to varying bulb 




Figure 3.21. Development of the PAZ5-KO (Knockout) Strain from 0 to 36 HPS. Cells were 
developed for 36 HPS. Images were captured using a 4X objective on an Olympus light 
microscope with a SPOT camera attachment. Color differences between this and other strains 




Figure 3.22. Development of T628A (5) PAZ5 Mutant Strain from 0 to 36 HPS. Cells were 
developed for 36 HPS. Images were captured using a 4X objective on an Olympus light 
microscope with a SPOT camera attachment. Color differences between this and other strains 




Figure 3.23. Development of C523G (6) PAZ5 Mutant Strain from 0 to 36 HPS. Cells were 
developed for 36 HPS. Images were captured using a 4X objective on an Olympus light 
microscope with a SPOT camera attachment. Color differences between this and other strains 




Figure 3.24. Development of H519L (15) PAZ5 Mutant Strain from 0 to 36 HPS. Cells were 
developed for 36 HPS. Captured using a 4X objective on an Olympus light microscope with a 
SPOT camera attachment. Color differences between this and other strains were due to varying 







 This study's focus was to determine if mutations to conserved amino acids in the DHHC-
CRD, DPG, and TTYE regions of PAZ5 would elicit a similar fruiting body malformation to those 
seen in the PAZ5-KO and DHHC-mutant strains. Moreover, as the mutations to the cysteines in 
the CRD have been shown to affect palmitoylation in an enzymatic model, it may be possible to 
show that cysteine disruption in PAZ5 elicits an observable change using an in vivo model, 
namely using D. discoideum. Correlation of the mutations to the known phenotype may allow 
for increased characterization of the PAZ family of proteins, and by extension, the DHHC family 
of palmitoyltransferases. 
  
4.1. Low Transformation Efficiency of PAZ5/pTX-GFP into D. discoideum 
 The process of transforming the 17 mutant PAZ5/pTX-GFP constructs into D. discoideum 
was mostly unsuccessful. Until recently, transformation using electroporation has been a very 
successful technique in the Gundersen lab. Electroporation is a mature technology for plasmid 
integration into the organism; iteratively explored parameters used to optimize the number of 
successful colonies has been known for decades (Pang et al., 1999). It is typical to obtain a 
single successful transformant per 1 x 105 cells; with a mean of 5 x 106 cells per transformation, 
50 successful colonies is the norm. However, of the seventeen mutations made to PAZ5, then 
integrated into the pTX-GFP vector, only six were transformed successfully over eight months. 




electroporated had successful colonies. Of these six transformants, four were unable to grow in 
shaking culture. All successful colonies were able to be grown in G418 selection media (20 
μg/mL, 13 μL per 13 mL HL-5), suggesting that the transformation had been a success. For some 
unsuccessful transformants, the cells that initially seemed to survive electroporation were killed 
by the G418 selection media before they could produce viable colonies. There have also been 
issues relating to fungal and bacterial contamination of the plates; though these have been 
solved, electroporation efficiency has still not improved. 
Attempts have been made to investigate what aspect of the procedure has been 
interfering with the efficiency. This issue has still not been rectified, though various methods 
have been attempted. Initially, it was thought that efficiency was being impacted by the 
distilled water used for buffers, so all buffers were remade using new water. Then issues with 
contamination of the plates appeared around 14 days after electroporation. The contamination 
was traced to the heat-killed bacteria, added to the initial transformants to aid in growth, not 
being entirely heat-killed, allowing for slow but sizeable growth to overwhelm the amoeboid 
cells. The antibiotic concentration was also lowered, which did initially help growth. However, 
this was deemed unviable because it allowed for the possibility of lower plasmid expression, 
and antibiotic concentration had never before been an issue with this plasmid before. Another 
plasmid, pCV5-YFP, was used to determine if the pTX-GFP plasmid was somehow responsible 
for the change in electroporation efficiency. However, pCV5 also had significantly lowered 
transformation efficiency. Only two colonies appeared on a single plate out of 16 total plates 
made over two weeks; moreover, these two colonies grew much more slowly than they did 




remaking all buffers using entirely new components or using a different gene pulser machine 
for the electroporation itself. There are also more modern methods of electroporation for D. 
discoideum using oscillating electric fields instead of the classic exponential decay 
electroporation technique that is currently the standard for D. discoideum transformation 
(Alibaud et al., 2003).  
 
4.2. Absence of Fluorescent Signal for PAZ5/pTX-GFP Strains  
 Before characterizing the PAZ5 protein using phenotypic analysis of the developmental 
lifecycle, fluorescence microscopy was to be used to study the localization of the expressed 
PAZ5-GFP in D. discoideum cells. Fluorescence, together with sustained growth in the G418 
selection media, would also be used to confirm that the pTX-GFP fusion expression vector was 
functioning correctly. All mutations in the PAZ5/pTX-GFP fusion expression vector failed to 
exhibit any fluorescence over the background. This lack of fluorescence was confirmed for all 
mutants, suggesting that the fault was due to a problem with the pTX-GFP vector itself rather 
than the transformation process. 
 Initially, it was thought that some cells were fluorescing. However, it was determined 
that the laser intensity settings were too high, creating ‘fuzzy’ artifacts that looked as though 
they were constitutively expressing a GFP signal in the entire cell (Figure 3.9). This was doubtful 
as the fluorescence resolution was inferior, and the fluorescence did not localize anywhere, nor 
did it appear to have mislocalized to the cytoplasm either. These artifacts also appeared in the 




 D. discoideum cells also exhibit autofluorescence. Resuspension in DB (Chapter 2.13) 
triggers their starvation response and reduces autofluorescence. However, this process still 
leaves a degree of autofluorescence within the cell. However, the GFP cassette in pTX-GFP 
should provide a far higher signal than background or autofluorescence; it should not be 
difficult to view. A previously successful pTX-GFP transformant from 2009 was thawed and 
grown from D. discoideum stock; this plasmid contained an unmutated PAZ8 protein ligated 
into pTX-GFP, PAZ8-GFP. This provided a positive control to vet the PAZ5/pTX-GFP line against. 
The PAZ8-GFP clonal line showed successful fluorescence and localized to the endoplasmic 
reticulum of the cell (Figure 3.12) as it had over a decade prior, though this had not been 
confirmed with an ER stain (Amburg, 2010). 
 It is still not known where the PAZ5 protein localizes to when it is expressed in D. 
discoideum. It is thought that the PAZ protein, like other DHHC proteins, would localize to the 
Golgi and ER. Previous attempts to examine PAZ5 fluorescence localization were hampered 
because the natural KpnI site within PAZ5 was not accounted for (Amburg, 2010). 
Consequently, the PAZ5-GFP construct that was created would mislocalize to the cytoplasm. 
This issue was corrected by mutating the KpnI site from GGTACC to GGTTCC, thereby keeping 
the valine intact but interrupting the ability of the KpnI enzyme to cleave the site.  
 The pCV5-YFP strain was chosen as a second positive control; it was used to determine 
whether the loss of fluorescence was related to the electroporation itself rather than an issue 
with the pTX-GFP plasmid directly. However, the pCV5-YFP, despite having very low 
electroporation efficiency as was the case with all the transformations in the recent past, was 




subunit of the G protein. As expected, it localized to the plasma membrane, Golgi, and ER of the 
cell (S. A. Alamer, 2018). It did so at the same settings used for capturing the PAZ8-GFP 
fluorescence; using a low enough laser voltage to avoid the background and autofluorescence 
of cells that lacked the GFP cassette. At these settings, it was confirmed again that the mutant 
PAZ5 strains in the PAZ5/pTX-GFP constructs were not expressing any fluorescence.  
As a result, it is surmised that the pTX-GFP plasmid may have had a loss of function, 
though precisely how or in what way is not known and requires further investigation and 
testing. It may be that the GFP cassette alone has ceased to function correctly. However, it is 
also possible that a promoter region is malfunctioning or that another part of the plasmid is the 
cause of the error. As mentioned in Chapter 3.2, all PAZ5/pTX-GFP ligations that were 
successful, insofar as PAZ5 ligated in the corrected orientation, were subsequently sequenced. 
Sequencing determined that the PAZ5 mutation was successful and that the ligation into the 
pTX-GFP vector was in-frame. As a side effect of Sanger sequencing, sequence reads up to 160 
bp upstream of the PAZ5 insertion and 450 bp downstream of the PAZ5 sequence was 
achieved. The problem was that as the read reaches its end, it degrades and drops bases, but in 
each case, the pTX-GFP sequence did not move out of frame, suggesting that there were no 
mutations in the area it reads up to. However, the pTX-GFP plasmid is 11.2 kb (Figure A.2 and 
Table A.2) in size, and only a maximum of 1 kb has been sequenced for all mutations outside of 
the 2.2 kb PAZ5 protein. What precisely was the cause of pTX-GFP losing fluorescence cannot 
be confirmed without designing a set of at least eight new primers in order to perform an entire 
sequence read of the vector. Or, instead of sequencing the entire plasmid, a Western Blot could 




PAZ5 insert. For the moment, without knowing what has changed, the validity of the 
phenotypic analyses of the developmental stage of D. discoideum has been called into question. 
 
4.3. Characterization of Knockout and Mutant Phenotypes 
 Previous work in the Gundersen lab has discovered that the DHHC domain of the PAZ5 
protein is essential for proper function in D. discoideum (Amburg, 2010). The first histidine in 
DHHC was converted to alanine, and separately the cysteine in DHHC was converted to serine. 
A PAZ5-KO mutant was also created by disrupting the PAZ5 protein with a 1.4 kb BLS resistance 
cassette midway through the sequence. It was found that both mutations elicited the same 
phenotypic change in fruiting body formation as the PAZ5-KO mutant. The change manifested 
as a reduced number of cellulose-producing stalk cells nearer the stalk base, leading to a 
collapse in the structure during spore migration up the stalk and growth along the agar surface 
instead of directly into the air. Moreover, the cells could be rescued with an intact PAZ5 
sequence, resulting in a phenotype indistinguishable from the wildtype. Taken together, this 
suggested that an intact DHHC domain was essential to PAZ5 function (Amburg, 2010).  
The notion that a DHHC site is essential to proper protein function, in this case, 
mediation of palmitoylation via the catalytic ping-pong mechanism, has more recently been 
confirmed via an enzymatic study of the DHHC catalytic domain of the human DHHC3 protein 
(Gottlieb et al., 2015). The authors note that a DHHC cysteine mutation to a serine rendered the 
protein catalytically inactive, with serine mutations to conserved cysteines in the DHHC-CRD 
either halting or reducing enzyme activity (Gottlieb et al., 2015). The authors also determined 




structure of the DHHC3 protein. Disruption was primarily linked to the loss of the intact CCHC 
zinc-fingers, as the conserved cysteines were unable to coordinate zinc; furthermore, the zinc-
binding function of the cysteines was found to exist solely as a structural role, rather than a 
catalytic or regulatory role (González Montoro et al., 2013; Gottlieb et al., 2015).  
 Despite studies into the DHHC motif and the conserved cysteines in the DHHC-CRD, 
there has been little work examining the function of other conserved residues in the DHHC-CRD 
or the conserved residues that make up the DPG and TTYE motifs that flank the DHHC-CRD. 
Thus, the work's basis was to further characterize the structure and function of the PAZ5 DHHC 
protein by performing multiple developmental studies with various mutations to these 
conserved residues in and around the DHHC-CRD.  
 A total of seventeen mutations were created for the study of PAZ5. Of these seventeen, 
two were created in the DPG and TTYE motifs, four were made to the CHHC zinc-fingers directly 
flanking the DHHC motif, and nine were made to conserved non-cysteine amino acids in the 
DHHC-CRD (Table 3.1). Mutations were created using site-directed mutagenesis to change 
either one or two nucleotides in the PAZ5 sequence. The type of mutation introduced varied 
depending on their purpose. Some were designed to elicit a substantial change, and others to 
elicit a smaller change. For example, some introduced large size differences (e.g., G477Y, 
C509G, etc.), others involved changing side-chain polarity (C506A, T628A, etc.) or side-chain 
group type (N538I, G542S, etc.) (Table 3.1). 
Of the seventeen mutations created in PAZ5, then ligated into the PAZ5/pTX-GFP fusion 
expression vector, only six were successfully transformed into D. discoideum using 




culture and examined via developmental study. The mutant T628A (5) involved a single base 
substitution that changed the first conserved threonine of the TTYE motif to an alanine. This 
mutation was a conserved substitution than a radical one. Threonine is generally considered a 
slightly polar amino acid; it is of medium size with a fairly reactive hydroxyl group and forms 
hydrogen bonds with many polar substrates (Betts & Russell, 2003). By comparison, alanine is 
non-polar, has low hydrophobicity, and is relatively small compared to other amino acids. The 
mutant C523G (6) used a single base substitution to change a conserved cysteine residue to a 
glycine, in the second CCHC zinc finger in the DHHC-CRD, a more radical substitution. Cysteines 
are small and non-polar; they tend not to show a preference for substitution with any other 
amino acid (Betts & Russell, 2003). As this cysteine has been implicated in binding zinc, a glycine 
was chosen to elicit a radical substitution. Though glycine is non-polar, it is disfavored for 
cysteine substitutions (Betts & Russell, 2003). 
The mutant R516P (9) involved an arginine to proline substitution, a radical substitution, 
as proline is disfavored as an arginine substitution. Arginine is a large, polar, basic, and 
positively charged amino acid that favors substitution to similar profiled amino acids. On the 
other hand, proline is much smaller, non-polar, and cyclic (Betts & Russell, 2003). The final 
mutation that was developmentally examined was H519L (15), a histidine to leucine 
substitution. The histidine was involved in the first CCHC zinc finger in the DHHC-CRD. The 
leucine substitution was considered a radical substitution. Histidine is generally polar, basic, 
positively charged, and does not commonly substitute with other amino acids. On the other 




As previously stated, fluorescence localization of these PAZ5/pTX-GFP mutants could 
not be identified. Taken together, this suggests that the plasmid has experienced a loss of 
function, though precisely what has gone wrong is currently unknown. Despite the loss of 
fluorescence and low transformation efficiencies, phenotypes for successful transformants 
were characterized, though it is unknown if they were expressing the mutant PAZ5/pTX-GFP 
expression vectors. However, it is important to keep in mind that since the extent of the 
plasmid dysfunction is still unknown, the phenotypes observed may not be entirely a result of 
the intended mutations or intended expression level. The fruiting bodies were divided into 
three categories: Those that had developed growing normally (upright); those that had fallen 
over and contacted the surface of the plate, breaking open the spore head (fallen); and those 
that developed along the agar, including those that formed a normal spore head slightly above 
the surface of the agar (along agar). 
The experiments suggest that the PAZ5-KO line produces significantly fewer fruiting 
bodies than the AX2 wild type, and the fruiting bodies produced for PAZ5-KO tended to collapse 
much more readily than the mainly upright fruiting bodies of the wildtype. In previous 
examinations of fruiting body development in PAZ5, the phenotypes' counts did not include 
analysis of the tight aggregate (mound) stage (Amburg, 2010). A clear difference between the 
AX2 wildtype and the other cell lines, excluding R516P, was an increase in the number of 
mounds relative to fruiting bodies. Two mutants did not move past the mound stage at all 
(T628A and C523G); in both cases, no fruiting bodies were present on any plates. However, it is 
odd that the PAZ5-KO phenotype, with a wholly disrupted PAZ5 protein, still produced fruiting 




flanking the DHHC domain. The R516P mutation was most similar to the wildtype with similar to 
the AX2 wildtype, rather than the PAZ5-KO phenotype, suggesting that despite the radical 
substitution, the conserved residue may not be integral to DHHC function. However, the 
fruiting bodies were small compared to fruiting bodies in the wildtype and PAZ5-KO strains. This 
is a phenotype that has not been observed in the Gundersen lab before. The final mutation, 
H519L, formed far more mounds than the PAZ5-KO strain, but unlike the T628A and C523G, this 
strain produced fruiting bodies. Like the R516P strain, these fruiting bodies were significantly 
smaller in size than the wildtype or PAZ5-KO, though most of them were still upright. However, 
it is important to keep in mind that very few fruiting bodies were observed as on some plates, 
almost all phenotypes were solely mounds.  
Besides the final phenotype count, movies of each strain were produced (except for 
R516P). The AX2 wildtype and PAZ5-KO lines showed similar initial growth until the aggregation 
stage. After initial mound differentiation, the wildtype cells that did not culminate continued to 
wander around until they accumulated more cells, wherein they began the second round of 
culmination. In comparison, PAZ5-KO showed much-delayed development in the mound stage 
and only produced a single round of culmination, as the mounds did not move around the agar 
surface after forming the tight aggregate. All the observed mutants were either delayed in 
aggregation or de-aggregated at least once before forming a mound. In all cases, mound 
culmination took much longer than even the PAZ5-KO strain, and many mounds tended not to 
differentiate at all.  
Calcofluor staining involves the binding of a fluorescent dye to polysaccharide polymers 




1984) (Table D.1). Using calcofluor-white staining, it is also possible to diagnose whether the 
fruiting bodies that have fallen over in the mutant strains share a similar root cause as the 
PAZ5-KO strain. This is because the PAZ5-KO strain was previously reported to have fewer 
cellulose-producing cells in the lower stalk region, which resulted in the fruiting body collapsing 
during spore movement up the stalk (Amburg, 2010). This difference in cell sorting also 
provides another means of comparing the change in cellular sorting and differentiation 
between the AX2 wildtype and the PAZ5-KO strains.  
The positive fluorescent control plasmid pCV5-YFP was created in 2018 for viewing 
localization and function of the Gα2 subunit of the G protein (S. A. Alamer, 2018). pCV5-YFP was 
transformed into the PAZ5-KO strain to determine if the loss of fluorescence seen in mutant 
strains of PAZ5 was tied to electroporation. As seen in Figure 3.13, the tagged Gα2 localized to 
the plasma membrane without rescuing the disabled PAZ5 protein. Suggesting that Gα2 was not 
palmitoylated by PAZ5, as it still appears bound to the plasma membrane without a functioning 
PAZ5 protein. As PATs with the DHHC-CRD are the only proteins that mediate S-palmitoylation, 
and the only DHHC PATs in D. discoideum are the 14 PAZ proteins, it stands to reason that a 
different PAZ protein must be responsible for Gα2 palmitoylation in D. discoideum. 
It was hypothesized that the PAZ5 mutants would produce developmental phenotypes 
that statistically fell between the wildtype and PAZ5-KO strains. This was because the AX2 
wildtype had a fully functional PAZ5 domain, whereas the PAZ5-KO strain had a BLS cassette 
inserted halfway through the sequence, functionally disrupting the entire protein. However, of 
the four mutants that were able to grow, only the R516P mutation fell in this domain. The other 




For this reason, the results observed are likely a product of the faulty pTX-GFP construct rather 
than as a direct result of the substitution mutations introduced. Without knowing the precise 
nature of what has changed in the construct, it is impossible to definitively say what effect it is 
having on the mutant PAZ5 protein expression during development.  
 
4.4. Potential Remedies for the Malfunctioning PAZ5/pTX-GFP Plasmid 
 Based primarily on the lack of fluorescence localization seen in any of the mutant 
PAZ5/pTX-GFP strains, and to a lesser extent on the unusual phenotypic development of the 
strains compared to both the wildtype and knockout, the pTX-GFP construct has likely had a 
loss of function. If this were the case, the most rapid way to diagnose what has gone wrong in 
the construct would be to sequence the entire 11.4 kb plasmid. The PAZ5 portion of the fusion 
expression vector has already been sequenced, as has the area around the ligation, confirming 
that the pTX-GFP vector is intact here. Hence, a set of at least eight new primers would need to 
be created in order to perform an entire sequence read of the vector. An indirect method of 
confirming the transformations would be to check for the direct presence of the pTX-GFP 
plasmid construct by using an antibody for the Poly-His tag present at the N-terminal end of 
PAZ5 in the fusion protein. These antibodies are widely available and a Western Blot test to 
confirm the antibody binding would be comparatively simple. However, performing these 
procedures may not be necessary as it does not resolve the issue directly. Fixing the root cause 
of the issue would be faster and likely more cost-efficient. 
 Instead, it may be wise to either order a fresh stock of the pTX-GFP vector and re-do all 




discoideum expression vector. The Gundersen lab has a pJK1 vector on hand that has been 
successfully used for development studies. The GFP could also be replaced with a YFP tag ready 
for insertion (Little, 2013). Before usage, the YFP tag would need to be inserted into the pJK1 
vector. One issue with pJK1 is that it uses a BglII (AGATCT) site instead of KpnI (GGTACC). This 
would necessitate adding either a BamHI (GGATCC) or BglII cassette to the end of the PAZ5 
protein, as these cohesive ends are compatible with one another (Vanamee et al., 2004).  
 It may also be the case that the lack of fluorescence is due to a problem with the 
attachment of the GFP to the PAZ5 protein. Fluorescent tagging of GFP to the PAZ5 protein has, 
in the past, suffered from poor characterization due to mis-localization (Amburg, 2010). 
However, this was later attributed to improper insertion of PAZ5 into the pTX-GFP construct, as 
the KpnI site naturally present in the PAZ5 sequence was not removed, likely cleaving PAZ5 as it 
was inserted into the expression plasmid. Yet, it is possible that the fluorescent protein is 
altering the function, localization, and detection, of the PAZ5 protein. It may be that the GFP is, 
for example, pH-sensitive and is failing to fluoresce in organelles that have different pH 
differences. This adds to the notion of using a different plasmid besides pTX-GFP for examining 
expression of PAZ5, as it may be that GFP is not the appropriate fluorescent tag to use for its 
developmental study. However, other PAZ proteins have successfully been studies using pTX-
GFP, such as PAZ8 and PAZ10 (Amburg, 2010). It was also previously observed that YFP-
attachments to the Gα2 subunit were rapidly lost if clonal lines were left to grow over weeks; 
instead, cells were grown from stocks that were frozen as soon as log-phase growth was 




similarly observed for fluorescence in the same way and still did not fluorescence, suggesting 
that the loss was not due to this phenomenon.  
 
4.5. Conclusions and Future Directions 
 This study was designed to further characterize the PAZ5 protein in D. discoideum as it 
relates to protein acyltransferase mediation by the DHHC domain. PAZ5 is the first of the 
fourteen DHHC-containing PAZ proteins identified by the Gundersen lab to have its DHHC 
domain characterized. Mutagenesis to the conserved DHHC motif had previously shown that an 
intact DHHC was essential to PAZ5 protein function. The study aimed to determine if other 
conserved residues flanking the DHHC motif were also essential to PAZ5 protein function, 
especially those that made up the two CCHC zinc fingers and the conserved DPG and TTYE 
domains outside the DHHC-CRD.  
Of the seventeen mutations designed to modify the PAZ5 protein function, only four 
were eventually studied due to D. discoideum electroporation efficiency issues. 
Characterization was further hampered due to a still as-of-yet unknown fault in the PAZ5/pTX-
GFP fusion expression vector. This fault has prevented the study of PAZ5 fluorescent 
localization in live cells. It has likely also disrupted the mutants' expression and distorted the 
statistical analysis of the fruiting body phenotype in developing cells. 
 The immediate focus should be to remedy what has gone wrong in the pTX-GFP 
plasmid; this can be accomplished by first confirming the presence of pTX-GFP in D. discoideum 
cells, then sequencing the vector to determine what may have changed. Following on, a new 




developmental study, such as pJK1-YFP. Successful fluorescence localization of PAZ5, when 
combined with qRT-PCR data from previous studies (Bodwell, 2007), may provide a powerful 
means of categorizing which substrates might be mediated by PAZ5 palmitoylation. This is 
especially relevant for the Gα2 subunit, which is known to be palmitoylated for localization to 
the plasma membrane (S. Alamer et al., 2018). D. discoideum provides a powerful in vivo 
approach to a field typically isolated to purely enzymatic study. Further analysis of fruiting body 
phenotypes that are correctly expressing the PAZ5 mutations may also lead to an increased 
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PAZ5 AND PTX-GFP RESTRICTION SITES AND SEQUENCES 
 
Figure A.1. Restriction Sites of PAZ5 with Mutated KpnI Site. Restriction sites for commonly 
available restriction enzymes are seen here, together with the relevant location within the 






Figure A.2. Diagram of the pTX-GFP Plasmid Vector. The pTX-GFP expression vector is shown, 
with mention to its restriction sites (KpnI in particular), ampicillin resistance (Amp), GFP coding 






















































































































































































































































































































































































































































































Table A.4. Amino Acid Composition of the PAZ5 Protein. 
Amino Acid Composition 
Ala[A] 30 4.0 % 
Arg[R] 23 3.1 % 
Asn[N] 47 6.3 % 
Asp[D] 35 4.7 % 
Cys[C] 15 2.0 % 
Gln[Q] 62 8.3 % 
Glu[E] 30 4.0 % 
Gly[G] 52 6.9 % 
His[H] 34 4.5 % 
Ile[I] 67 8.9 % 
Leu[L] 66 8.8 % 
Lys[K] 37 4.9 % 
Met[M] 14 1.9 % 
Phe[F] 37 4.9 % 
Pro[P] 33 4.4 % 
Ser[S] 58 7.7 % 
Thr[T] 29 3.9 % 
Trp[W] 13 1.7 % 
Tyr[Y] 34 4.5 % 













PAZ5 MUTANT SEQUENCE ALIGNMENTS 
 




G477Y           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
G477Y           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
G477Y           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
G477Y           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
G477Y           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
G477Y           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
G477Y           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
G477Y           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPYTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ******************************************************** *** 
 
G477Y           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ************************************************************ 
 
G477Y           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
G477Y           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
G477Y           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
G477Y           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 




Table B.2. Sequence Alignment for Mutant C506A (2). The mutation created was a C506R 










C506A           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
C506A           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
C506A           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
C506A           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
C506A           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
C506A           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
C506A           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
C506A           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
C506A           KHISKEKSNENFMNALSSGRQIPLIRPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ************************* ********************************** 
 
C506A           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
C506A           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
C506A           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
C506A           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 















C509G           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
C509G           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
C509G           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
C509G           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
C509G           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
C509G           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
C509G           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
C509G           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
C509G           KHISKEKSNENFMNALSSGRQIPLICPTGLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                **************************** ******************************* 
 
C509G           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
C509G           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
C509G           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
C509G           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 















D475A           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
D475A           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
D475A           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
D475A           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
D475A           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
D475A           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
D475A           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
D475A           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEAPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ****************************************************** ***** 
 
D475A           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ************************************************************ 
 
D475A           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
D475A           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
D475A           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
D475A           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 















T628A           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
T628A           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
T628A           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
T628A           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
T628A           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
T628A           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
T628A           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
T628A           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
T628A           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ************************************************************ 
 
T628A           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
T628A           FSIYGIGMAIWIGKLAISQVLTILFNKATYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ***************************:******************************** 
 
T628A           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
T628A           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 




Table B.6. Sequence Alignment for Mutant C523G (6). 
 
  
C523G           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
C523G           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
C523G           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
C523G           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
C523G           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
C523G           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
C523G           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
C523G           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
C523G           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSGKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ****************************************** ***************** 
 
C523G           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
C523G           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
C523G           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
C523G           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 















E631A           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
E631A           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
E631A           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
E631A           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
E631A           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
E631A           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
E631A           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
E631A           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
E631A           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHHCVWINK 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFD-HHCVWINK 
                *************************************************** ******** 
 
E631A           CIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFIL 
PAZ5            CIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFIL 
                ************************************************************ 
 
E631A           LFSIYGIGMAIWIGKLAISQVLTILFNKTTYAQIQQIREFESRQGHGHSHGGDQQCNHSH 
PAZ5            LFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSH 
                ******************************* **************************** 
 
E631A           GSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDM 
PAZ5            GSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDM 
                ************************************************************ 
 
E631A           YHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            YHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 














P514A           ------PPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                      ****************************************************** 
 
P514A           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
P514A           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
P514A           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
P514A           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
P514A           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
P514A           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
P514A           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
P514A           KHISKEKSNENFMNALSSGRQIPLICPTCLINRAIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                *********************************.************************** 
 
P514A           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
P514A           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
P514A           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
P514A           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 




Table B.9. Sequence Alignment for Mutant R516P (9). The read error in the lower-middle was 










R516P           MIPTPNPPQG---NQNDEFIIIKPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQN 
PAZ5            MIPTQTPPRQQMMNHNHQ-----PQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQI 
                **** .**.    *:* :     ************************************  
 
R516P           CNTKSNDLNYPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQE 
PAZ5            V-TPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQE 
                  * .: :: ************************************************** 
 
R516P           YRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKA 
PAZ5            YRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKA 
                ************************************************************ 
 
R516P           MVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHA 
PAZ5            MVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHA 
                ************************************************************ 
 
R516P           AQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQG 
PAZ5            AQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQG 
                ************************************************************ 
 
R516P           RTAFHWGCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKL 
PAZ5            RTAFHWGCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKL 
                ************************************************************ 
 
R516P           KDDKLFGGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYW 
PAZ5            KDDKLFGGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYW 
                ************************************************************ 
 
R516P           VPERNNWLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLMQPRGTFSTFSFVQR---- 
PAZ5            VPERNNWLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKE 
                *****************************************:    ::  * *. *     
 
R516P           ---KIQAQFLNISLKRNQMKTL----MLSQVVVKSLFVQPVLIVQFLQNIVHLVKVVLHV 
PAZ5            DPGTISKHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHC 
                   .*. :: : . : * *::*     :. :  ..*: .*:   :  .    :...  *  
 
R516P           LIIIVFGYKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLF 
PAZ5            VWI----NKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLF 
                : *     **************************************************** 
 
R516P           YYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHG 
PAZ5            YYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHG 
                ************************************************************ 
 
R516P           GDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSF 
PAZ5            GDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSF 
                ************************************************************ 
 
R516P           HNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTEIFMLIQEF 
PAZ5            HNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 















W536L           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
W536L           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
W536L           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
W536L           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
W536L           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
W536L           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
W536L           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
W536L           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
W536L           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVLINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ******************************************************* **** 
 
W536L           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
W536L           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
W536L           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
W536L           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 















N538I           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
N538I           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
N538I           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
N538I           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
N538I           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
N538I           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
N538I           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
N538I           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
N538I           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWIIKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ********************************************************* ** 
 
N538I           IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ************************************************************ 
 
N538I           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
N538I           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
N538I           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 














G542S           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
G542S           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
G542S           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
G542S           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
G542S           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
G542S           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
G542S           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
G542S           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
G542S           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ************************************************************ 
 
G542S           ISINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                *.********************************************************** 
 
G542S           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
G542S           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
G542S           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 















F549V           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
F549V           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
F549V           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
F549V           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
F549V           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
F549V           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
F549V           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
F549V           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
F549V           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ************************************************************ 
 
F549V           IGINNQALVITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ********.*************************************************** 
 
F549V           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
F549V           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
F549V           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 




Table B.14. Sequence Alignment for Mutant F549S (14). Incomplete read at 5’ end, believed to 










F549S           DTNTNTPKTTNDESSSTTTNTTTTTNTTTSTTTTTTTSITIGKCRNSIFTNCNTKSNDIT 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQF----RPLDENAEIPFLQIV 
                   *:**   :  . .  .:    .:   .  .    .  :    ..:  *.:    :*. 
 
F549S           TNVSRTITIIKMVKSMYKIWIIIYSSSTISSFGIIRNCKWYSRIRFHSSNYVKSKRWKRI 
PAZ5            TP-NQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLL---------------YTQAVPYNQV 
                *  .. *.:  *.:. **  :  :*.. *.. *::               *.::  ::.: 
 
F549S           NSTTTTTTTINIKINNKFNRFRRYINSLCNYEKESNG--------------LFNLWCKFR 
PAZ5            ------LVLLEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIIN 
                       . ::*  *..:: :* :*: : : :::.:*               :.*.. :. 
 
F549S           YSKFRGRS---YTI---TLGMYSRFIIC------------VTIGKWCRYSFDEG--LQCI 
PAZ5            LIDLEGNTSIHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLV 
                  .: *.:   *:*   . .* * :* *             *  :*.  . *..  ** : 
 
F549S           TSCCTIS-----EFSALFNERIGPQCNAKTF----------SKDIQLHTAVHWTSFQGHA 
PAZ5            ENGADIHLTDKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHA 
                 . . *       :.**::     : *:  :          .****************** 
 
F549S           NMARYFISLGVDPNAQDIQGRTAFHWGCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTA 
PAZ5            NMARYFISLGVDPNAQDIQGRTAFHWGCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTA 
                ************************************************************ 
 
F549S           YQLAESKEHYEIIDYLDTKLKDDKLFGGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFG 
PAZ5            YQLAESKEHYEIIDYLDTKLKDDKLFGGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFG 
                ************************************************************ 
 
F549S           LPLLAVGGYFLKNYLHLNYWVPERNNWLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPN 
PAZ5            LPLLAVGGYFLKNYLHLNYWVPERNNWLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPN 
                ************************************************************ 
 
F549S           LIINATSWYFFYFFIRLTKEDPGTISKHISKEKSNENFMNALSSGRQIPLICPTCLINRP 
PAZ5            LIINATSWYFFYFFIRLTKEDPGTISKHISKEKSNENFMNALSSGRQIPLICPTCLINRP 
                ************************************************************ 
 
F549S           IRSKHCPSCKGCFARFDHHCVWINKCIGINNQALSITVLFSYVILVISGFIVTWDYFKSD 
PAZ5            IRSKHCPSCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSD 
                ********************************** ************************* 
 
F549S           SNAPILSESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQ 
PAZ5            SNAPILSESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQ 
                ************************************************************ 
 
F549S           QIREFESRQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPS 
PAZ5            QIREFESRQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPS 
                ************************************************************ 
 
F549S           LPSSSGGSKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            LPSSSGGSKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 















H519L           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
H519L           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
H519L           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
H519L           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
H519L           NSVRYLIEKGLDPVQCKDIQFTYCQCIGPWFSXV-HANMARYFHKVGVDPKCTKTFQGRT 
PAZ5            NSVRYLIEKGLDPVQCKDIQL---HTAVHWTSFQGHANMARYFISLGVDPNA-QDIQGRT 
                ********************:   :    * *   ******** .:****:. : :**** 
 
H519L           AFPLGVVSKVTNKWSACYVHSKVKIVIKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKD 
PAZ5            AFHWGCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKD 
                **  * :.  .:  *    ..  . : ********************************* 
 
H519L           DKLFGGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVP 
PAZ5            DKLFGGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVP 
                ************************************************************ 
 
H519L           ERNNWLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDP 
PAZ5            ERNNWLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDP 
                ************************************************************ 
 
H519L           GTISKHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKLCPSCKGCFARFDHHCVW 
PAZ5            GTISKHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVW 
                ****************************************** ***************** 
 
H519L           INKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYP 
PAZ5            INKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYP 
                ************************************************************ 
 
H519L           FILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCN 
PAZ5            FILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCN 
                ************************************************************ 
 
H519L           HSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTN 
PAZ5            HSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTN 
                ************************************************************ 
 
H519L           FDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            FDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 




Table B.16. Sequence Alignment for Mutant F530S (16). Incomplete read at 5’ end, believed to 










F530S           -NKYNNHNKYNHINHNNN-------NHINLDHWMKMQKFHFYKLHQ-IKLNYHQCFKNNI 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPN- 
                    :.  . : :***::       ::*:  :  : * .:*  * :  :: : * .. *  
 
F530S           NNYIDGQINVLKNLDYYILKQYHIIKFWYYKLLK--------MVIFKNIEISFKLLSQIK 
PAZ5            --------QMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGD 
                        :::*    :  :  :::: *  : :*         * :::: : ::: .: . 
 
F530S           IKMVMKMKNQFNNNNNNNNHNQIIKVIHQFIMQLERIKQWLVILIVVQ-------IIFKI 
PAZ5            IQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRK 
                *:   .: : : :.*:*:: ::  : *:*   * :   : :: ** ::        *:.  
 
F530S           RKVIHHYI--------------GHVLKQIHHLCYNWLKMVQIFILIRGVTMHYF------ 
PAZ5            NKAMVSYLIDCGANLDIQNLEEGHT--PLHWACIKADSSFVLQLVENGADIHLTDKRGYN 
                .*.:  *:              **.   :*. * :  . . : :: .*. :*         
 
F530S           -MLHNIM--KIQCV--ILRKDWTPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNA 
PAZ5            ALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNA 
                 :**     :::.*  :: *.  ************************************* 
 
F530S           QDIQGRTAFHWGCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDY 
PAZ5            QDIQGRTAFHWGCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDY 
                ************************************************************ 
 
F530S           LDTKLKDDKLFGGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYL 
PAZ5            LDTKLKDDKLFGGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYL 
                ************************************************************ 
 
F530S           HLNYWVPERNNWLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFI 
PAZ5            HLNYWVPERNNWLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFI 
                ************************************************************ 
 
F530S           RLTKEDPGTISKHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFAR 
PAZ5            RLTKEDPGTISKHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFAR 
                ************************************************************ 
 
F530S           FDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFL 
PAZ5            FDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFL 
                ************************************************************ 
 
F530S           FYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSH 
PAZ5            FYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSH 
                ************************************************************ 
 
F530S           GGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKS 
PAZ5            GGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKS 
                ************************************************************ 
 
F530S           FHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            FHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRV 











Q546L           MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
PAZ5            MIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQ 
                ************************************************************ 
 
Q546L           MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
PAZ5            MIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQ 
                ************************************************************ 
 
Q546L           VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
PAZ5            VIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLI 
                ************************************************************ 
 
Q546L           DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
PAZ5            DCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEV 
                ************************************************************ 
 
Q546L           NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
PAZ5            NSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHW 
                ************************************************************ 
 
Q546L           GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
PAZ5            GCIKGHKQVVSMLCSFEGQDSIDKTIRDNDGKTAYQLAESKEHYEIIDYLDTKLKDDKLF 
                ************************************************************ 
 
Q546L           GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
PAZ5            GGNERLYHRFWTVMGVLTVLVPTWILCYVPVIFGLPLLAVGGYFLKNYLHLNYWVPERNN 
                ************************************************************ 
 
Q546L           WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
PAZ5            WLLPSILYSSVSIWYLIYLLRIAPLVMAINIFPNLIINATSWYFFYFFIRLTKEDPGTIS 
                ************************************************************ 
 
Q546L           KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
PAZ5            KHISKEKSNENFMNALSSGRQIPLICPTCLINRPIRSKHCPSCKGCFARFDHHCVWINKC 
                ************************************************************ 
 
Q546L           IGINNLALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
PAZ5            IGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILSESYIQSFLFYYTNYPFILL 
                ***** ****************************************************** 
 
Q546L           FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
PAZ5            FSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFESRQGHGHSHGGDQQCNHSHG 
                ************************************************************ 
 
Q546L           SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
PAZ5            SGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGGSKKDSDKSFHNQQTNFDMY 
                ************************************************************ 
 
Q546L           HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 
PAZ5            HRGVVNNVKEFLFDSQKFYFQTENIYADSRV 





MUTANT PAZ5/PTX-GFP FUSION SEQUENCE ALIGNMENTS 
 










G477Y-5'             KMHHHHHHHHDIGTWKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRP 
PAZ5/PTX-GFP-5'      KMHHHHHHHHDIGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRP 
                     ************** ********************************************* 
 
G477Y-5'             LDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVL 
PAZ5/PTX-GFP-5'      LDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVL 
                     ************************************************************ 
 
G477Y-5'             LEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTS 
PAZ5/PTX-GFP-5'      LEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTS 
                     ************************************************************ 
 
G477Y-5'             IHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLT 
PAZ5/PTX-GFP-5'      IHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLT 
                     ************************************************************ 
 
G477Y-5'             DKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDI------------------------ 
PAZ5/PTX-GFP-5'      DKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISL 
                     ************************************                         
 
 
G477Y-3'             ---------------------------------------ISGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                            ********************* 
 
G477Y-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
G477Y-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
G477Y-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
G477Y-3'             GVVPILVELDGDVNGHKFFCQWRGRCNI---RKTYPFICHYWKTTLFHGPTLGHYFRVWV 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPW-PTLVTTF-AYG 
                     ******************  .  *  :    . *  ***   * .: . ***   * .:  
 
G477Y-3'             FNALAKIL-RSKQHDLFQEWPCRKVMYRKELIFF 
PAZ5/PTX-GFP-3'      LQCFARYPDHMKQHDFFK--SAMPEGY------- 

















C506A-5'             IPNKKKMDSKIVFSFSSCFQMHKKIFFFSINKIKIKIKSDPKLKNASSSSSSSYRYHKKY 
PAZ5/PTX-GFP-5'      -----KMH-------------HHHHHHHDIGTMKKMIPT--------------------- 
                          **              *:: ....*..:*  * :                      
 
C506A-5'             QHKHPQDNKLMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMI 
PAZ5/PTX-GFP-5'      --QTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMI 
                       : *  :::************************************************** 
 
C506A-5'             KLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVI 
PAZ5/PTX-GFP-5'      KLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVI 
                     ************************************************************ 
 
C506A-5'             IESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDC 
PAZ5/PTX-GFP-5'      IESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDC 
                     ************************************************************ 
 
C506A-5'             GANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNS 
PAZ5/PTX-GFP-5'      GANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNS 
                     ************************************************************ 
 
C506A-5'             VRYLIEKGLDPVQCK--------------------------------------------- 
PAZ5/PTX-GFP-5'      VRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHWGC 
                     ***************                                              
 
C506A-3'             ------------------------------------------FIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                               ****************** 
 
C506A-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
C506A-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
C506A-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
C506A-3'             GVVPILVELDGDVNGAQIFCQWRGRCNIRKTY-PIYLHYWKTTCSMANTCHYFRVWSSML 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGD--ATYGKLTLKFICTTGKLPVP------W---- 
                     *************** ::  .  *  :   **  : *::  ** .:. .      *     
 
C506A-3'             CEIPQIINSMTFSRVPCLEGYVQERLLF-FQRRELQDTCSQLKVITLVIDRVKVLIRR 
PAZ5/PTX-GFP-3'      ---PTLVTTFAYG-LQCFARYPDHMKQHDFFKSAMPEGY------------------- 



















C509G-5'             KMHHHHHHHHDIGTLKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRP 
PAZ5/PTX-GFP-5'      KMHHHHHHHHDIGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRP 
                     **************:********************************************* 
 
C509G-5'             LDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVL 
PAZ5/PTX-GFP-5'      LDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVL 
                     ************************************************************ 
 
C509G-5'             LEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTS 
PAZ5/PTX-GFP-5'      LEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTS 
                     ************************************************************ 
 
C509G-5'             IHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLT 
PAZ5/PTX-GFP-5'      IHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLT 
                     ************************************************************ 
 
C509G-5'             DKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCK-------------------------- 
PAZ5/PTX-GFP-5'      DKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISL 
                     **********************************                           
 
C509G-3'             ------------------------------------------FIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                               ****************** 
 
C509G-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
C509G-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
C509G-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
C509G-3'             GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTPIYFALLENYLFHGQHLSLLSRMVFN 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGK--LPVPWPTLVTTFAYG 
                     **********************************  ::.   :  :   . :*:: :.:. 
 
C509G-3'             ALRRILRSYETALFQSACSRLLYREKNLYFSKM---- 
PAZ5/PTX-GFP-3'      L--QCFARYPDHM----------KQHDFFKSAMPEGY 



















D475A-5'             AEKKLLKLVVLLNLIQKKNGSNFCILLSLCFRCIKKDFFFFLFLNKINKKSDPKLKNASS 
PAZ5/PTX-GFP-5'      ---KMHH--------HHHHHHDIGTMKKM-----------------IPTQTPPR------ 
                        *: :        ::::  ::  : .:                 * .:: *.       
 
D475A-5'             SSSSSYRYHKKYQHKHPQDNKIIIIKPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPF 
PAZ5/PTX-GFP-5'      --------QQMMNHNH---------QPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPF 
                             ::  :*:*         :********************************** 
 
D475A-5'             LQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDI 
PAZ5/PTX-GFP-5'      LQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDI 
                     ************************************************************ 
 
D475A-5'             QEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKN 
PAZ5/PTX-GFP-5'      QEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKN 
                     ************************************************************ 
 
D475A-5'             KAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALL 
PAZ5/PTX-GFP-5'      KAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALL 
                     ************************************************************ 
 
D475A-5'             HAAQYNEVNSVRYLIEKGLDPVQCKDI--------------------------------- 
PAZ5/PTX-GFP-5'      HAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDI 
                     ***************************                                  
 
D475A-3'             --------------------------------------VISGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                           ********************** 
 
D475A-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
D475A-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
D475A-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
D475A-3'             GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKIYLHYWENYLFPWPTLVTTFRVWS 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLK-FICTTGKLPVPWPTLVTTF---- 



















T628A-5'             STNLVNINNQDPKLKNGIIIIIIIMISVPMEKYQHKHPPGQQMMNHNHQTQQIQQPQQIQ 
PAZ5/PTX-GFP-5'      KMHHHHHHHHD--------------IGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQ 
                     . :  : :::*              *..  :    : ** *********.********** 
 
T628A-5'             PHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGL 
PAZ5/PTX-GFP-5'      PHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGL 
                     ************************************************************ 
 
T628A-5'             LYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTL 
PAZ5/PTX-GFP-5'      LYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTL 
                     ************************************************************ 
 
T628A-5'             KSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSF 
PAZ5/PTX-GFP-5'      KSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSF 
                     ************************************************************ 
 
T628A-5'             VLQLVENGADIHLTDKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCK------------ 
PAZ5/PTX-GFP-5'      VLQLVENGADIHLTDKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTS 
                     ************************************************             
 
T628A-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
T628A-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKATYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     **********************************************:************* 
 
T628A-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
T628A-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
T628A-3'             GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPNTCHYFRVWSS 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
                     *************************************************.    *    . 
 
T628A-3'             MLCEIPRIIKQHDFFQEWPCPRVMYRKRPIIFPK-- 
PAZ5/PTX-GFP-3'      CFARYPDHMKQHDFFKS-------------AMPEGY 

















C523G-5'             KKSTGFSCHVFFQMHKRIFFFLFTIIINKNKIRSQAKNASSSSSSSYRYMKKMIPTQTPP 
PAZ5/PTX-GFP-5'      ------KMHHHHHHHHDI-----------------------------GTMKKMIPTQTPP 
                           . * ..: *: *                               *********** 
 
C523G-5'             RQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMIKLPPMF 
PAZ5/PTX-GFP-5'      RQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMIKLPPMF 
                     ************************************************************ 
 
C523G-5'             QEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVIIESNQN 
PAZ5/PTX-GFP-5'      QEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVIIESNQN 
                     ************************************************************ 
 
C523G-5'             KDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDCGANLDI 
PAZ5/PTX-GFP-5'      KDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDCGANLDI 
                     ************************************************************ 
 
C523G-5'             QNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNSVRYLIE 
PAZ5/PTX-GFP-5'      QNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNSVRYLIE 
                     ************************************************************ 
 
C523G-5'             KGLDPVQCK--------------------------------------------------- 
PAZ5/PTX-GFP-5'      KGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHWGCIKGHKQ 
                     *********     
 
                                                
C523G-3'             ------------------------------------------FIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                               ****************** 
 
C523G-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
C523G-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
C523G-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
C523G-3'             GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
                     ************************************************************ 
 
C523G-3'             CFARYPDHMKQHDFFKSAMPEGYVQEKTIFFQRRGTTRHVLKSRLRIPLYRSSLKVFDFK 
PAZ5/PTX-GFP-3'      CFARYPDHMKQHDFFKSAMPEGY------------------------------------- 

















E631A-5'             KKMVSKLVYQFYLYFSDAKDFFFFYSLKRYLLKNSIPKPNASSSSSSSSVPLKKYQHQTP 
PAZ5/PTX-GFP-5'      K------MHHHHHHHHDIG------TMKKMIPTQTPPRQ-------------QMMNHNHQ 
                     *      :::.: :. *        ::*. : .:: *.              :  :*:   
 
E631A-5'             PKTTKIIIINTTIHSTQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMIKLPPMFQE 
PAZ5/PTX-GFP-5'      PQQIQ--------QPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMIKLPPMFQE 
                     *:  :        :. ******************************************** 
 
E631A-5'             QYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVIIESNQNKD 
PAZ5/PTX-GFP-5'      QYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVIIESNQNKD 
                     ************************************************************ 
 
E631A-5'             GDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDCGANLDIQN 
PAZ5/PTX-GFP-5'      GDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDCGANLDIQN 
                     ************************************************************ 
 
E631A-5'             LEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNSVRYLIEKG 
PAZ5/PTX-GFP-5'      LEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNSVRYLIEKG 
                     ************************************************************ 
 
E631A-5'             LDPVQCKDI--------------------------------------------------- 
PAZ5/PTX-GFP-5'      LDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHWGCIKGHKQVV 
                     *********                                                    
 
E631A-3'             ---------------------------------------ISGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                            ********************* 
 
E631A-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYAQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************* ********** 
 
E631A-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
E631A-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
E631A-3'             GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
                     ************************************************************ 
 
E631A-3'             CFARIPRSY-ETALFRSAMPRLCTGKNLIIFQDDGY 
PAZ5/PTX-GFP-3'      CFARYPDHMKQHDFFKSAMP-------------EGY 

















P514A-5'             KNGKNLGWLIYLEFTKKKKMDSKLFFLLFFFRMHKKDFFFSILNKINKKNQIPSKMHHHH 
PAZ5/PTX-GFP-5'      ------------------------------------------------------KMHHHH 
                                                                           ****** 
 
P514A-5'             HHHHDIGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAE 
PAZ5/PTX-GFP-5'      HHHHDIGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAE 
                     ************************************************************ 
 
P514A-5'             IPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKN 
PAZ5/PTX-GFP-5'      IPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKN 
                     ************************************************************ 
 
P514A-5'             GDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIM 
PAZ5/PTX-GFP-5'      GDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIM 
                     ************************************************************ 
 
P514A-5'             RKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYN 
PAZ5/PTX-GFP-5'      RKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYN 
                     ************************************************************ 
 
P514A-5'             ALLHAAQYNEVNSVRYLIEKGLDPVQCKDI------------------------------ 
PAZ5/PTX-GFP-5'      ALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNA 
                     ******************************                               
 
P514A-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
P514A-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
P514A-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
P514A-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
P514A-3'             GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
                     ************************************************************ 
 
P514A-3'             CFARYPDHMKQHDFFRVPCPKVMYRKELYFSKMTGTTRTRAEVKFEGDNSFVIRIRSRLL 
PAZ5/PTX-GFP-3'      CFARYPDHMKQHDFFKSAMPEGY------------------------------------- 

















R516P-5'             ILKKCKTGGIYEINHKKKMDSNSLFFVFSCQMHKKIFFFFFYSKTNKIKKNQIPSKMHHH 
PAZ5/PTX-GFP-5'      -------------------------------------------------------KMHHH 
                                                                            ***** 
 
R516P-5'             HHHHHDIGTLKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENA 
PAZ5/PTX-GFP-5'      HHHHHDIGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENA 
                     *********:************************************************** 
 
R516P-5'             EIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAK 
PAZ5/PTX-GFP-5'      EIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAK 
                     ************************************************************ 
 
R516P-5'             NGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAI 
PAZ5/PTX-GFP-5'      NGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAI 
                     ************************************************************ 
 
R516P-5'             MRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGY 
PAZ5/PTX-GFP-5'      MRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGY 
                     ************************************************************ 
 
R516P-5'             NALLHAAQYNEVNSVRYLIEKGLDPVQCKD------------------------------ 
PAZ5/PTX-GFP-5'      NALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPN 
                     ******************************                               
 
R516P-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
R516P-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
R516P-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
R516P-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
R516P-3'             GVVPILVELDGDVNGHKFFCQWRGRCNIR-KNLPLNLFALLGKLPVPWPTLVTTFAYGLQ 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
                     ******************  .  *  :    :*.*:::.  ******************* 
 
R516P-3'             CFGEIPRSYETALFSRSGHARRVMYRKRTNIFKRRGTTKTRGS 
PAZ5/PTX-GFP-3'      CFARYPD-----------------HMKQHDFFK---SAMPEGY 

















W536L-5'             KKKWIPKSCFFVYVSSDAKRFFFFFLFNNKIIKNKIRSQAKNASSSSSSSYRYMKKMIPT 
PAZ5/PTX-GFP-5'      ----------------------------------KMHHHHHHHHDIGT-----MKKMIPT 
                                                       *:. : ::  . .:     ******* 
 
W536L-5'             QTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMIKL 
PAZ5/PTX-GFP-5'      QTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMIKL 
                     ************************************************************ 
 
W536L-5'             PPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVIIE 
PAZ5/PTX-GFP-5'      PPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVIIE 
                     ************************************************************ 
 
W536L-5'             SNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDCGA 
PAZ5/PTX-GFP-5'      SNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDCGA 
                     ************************************************************ 
 
W536L-5'             NLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNSVR 
PAZ5/PTX-GFP-5'      NLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNSVR 
                     ************************************************************ 
 
W536L-5'             YLIEKGLDPVQCKDI--------------------------------------------- 
PAZ5/PTX-GFP-5'      YLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHWGCIK 
                     ***************                                              
 
W536L-3'             --------------------------------------VISGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                           ********************** 
 
W536L-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
W536L-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
W536L-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
W536L-3'             GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
                     ************************************************************ 
 
W536L-3'             CFARYPDHMKQHDFFKSAMARRLCYRKELYFSKMTELQEHVLKSSLKVIPLLIDRVKRLL 
PAZ5/PTX-GFP-3'      CFARYPDHMKQHDFFKSAMPEGY------------------------------------- 



















N538I-5'             AKMHHHHHHHHDIGTLKKMIPTQTPPKTQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFR 
PAZ5/PTX-GFP-5'      -KMHHHHHHHHDIGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFR 
                      **************:**********. ******************************** 
 
N538I-5'             PLDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLV 
PAZ5/PTX-GFP-5'      PLDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLV 
                     ************************************************************ 
 
N538I-5'             LLEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNT 
PAZ5/PTX-GFP-5'      LLEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNT 
                     ************************************************************ 
 
N538I-5'             SIHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHL 
PAZ5/PTX-GFP-5'      SIHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHL 
                     ************************************************************ 
 
N538I-5'             TDKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDI----------------------- 
PAZ5/PTX-GFP-5'      TDKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFIS 
                     *************************************                        
 
N538I-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
N538I-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
N538I-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
N538I-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
N538I-3'             GVVPILVELDGDVNGHKFSVSGEGRCNIR--KTYPIYLHYWENYLFHGQHLSLLFAYGLQ 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFAYGLQ 
                     ************************  :    *    ::    :  .    *   ****** 
 
N538I-3'             CFARYPDHMKQHGLFQGVPWPKVMYRKELIFFQDDGTTDTCSQVWKVILLLDRVKR 
PAZ5/PTX-GFP-3'      CFARYPDHMKQHDFFKSA--------------MPEGY------------------- 



















G542S-5'             PSLKMHHHHHHHHDIGTIEKNDTNTNTPKTT-NDESSSTQQIQQPQQIQPHQPQQQQPHQ 
PAZ5/PTX-GFP-5'      ---KMHHHHHHHHDIGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQ 
                        **************::*  .. ..*.    : . ..********************* 
 
G542S-5'             FRPLDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQV 
PAZ5/PTX-GFP-5'      FRPLDENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQV 
                     ************************************************************ 
 
G542S-5'             LVLLEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEG 
PAZ5/PTX-GFP-5'      LVLLEIAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEG 
                     ************************************************************ 
 
G542S-5'             NTSIHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADI 
PAZ5/PTX-GFP-5'      NTSIHYAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADI 
                     ************************************************************ 
 
G542S-5'             HLTDKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCK----------------------- 
PAZ5/PTX-GFP-5'      HLTDKRGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYF 
                     *************************************                        
 
G542S-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
G542S-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
G542S-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
G542S-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
G542S-3'             GVVPILVELDGDVNGHKFFC--QWRGRCNIRKTPFKFICTTGKLPVSMANTLSLLFAYGL 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWP-TLVTTFAYGL 
                     ******************    :  * ..  * .:***********. . **   ***** 
 
G542S-3'             QCFAKIPRIINSMTFFKSAMPEGLCNRKELLFFQKNGRGTNKTRAESQ 
PAZ5/PTX-GFP-3'      QCFARYPDHMKQHDFFKSAMPEGY------------------------ 



















F549V-5'             KNVKTCVILNTIKNGQTSVFFSVIRCIKDFFFFFYSKTNNKIKIKSDPSKMHHHHHHHHD 
PAZ5/PTX-GFP-5'      -------------------------------------------------KMHHHHHHHHD 
                                                                      *********** 
 
F549V-5'             IGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQ 
PAZ5/PTX-GFP-5'      IGTMKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQ 
                     ************************************************************ 
 
F549V-5'             IVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQE 
PAZ5/PTX-GFP-5'      IVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQE 
                     ************************************************************ 
 
F549V-5'             YRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKA 
PAZ5/PTX-GFP-5'      YRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKA 
                     ************************************************************ 
 
F549V-5'             MVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHA 
PAZ5/PTX-GFP-5'      MVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHA 
                     ************************************************************ 
 
F549V-5'             AQYNEVNSVRYLIEKGLDPVQCKDI----------------------------------- 
PAZ5/PTX-GFP-5'      AQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQG 
                     *************************                                    
 
 
F549V-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
F549V-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
F549V-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
F549V-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
F549V-3'             GVVPILVELDGDVNGHKFSCQWRRVKVMQHTGKLTLKFIWHYKTTLFHGPTLVTNFRVWV 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATY-GKLTLKFICTTGKLPVPWPTLVTTFAY-- 



















H516L-5'             QHKHPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMI 
PAZ5/PTX-GFP-5'      --QTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMI 
                       : ******************************************************** 
 
H516L-5'             KLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVI 
PAZ5/PTX-GFP-5'      KLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVI 
                     ************************************************************ 
 
H516L-5'             IESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDC 
PAZ5/PTX-GFP-5'      IESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDC 
                     ************************************************************ 
 
H516L-5'             GANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNS 
PAZ5/PTX-GFP-5'      GANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNS 
                     ************************************************************ 
 
H516L-5'             VRYLIEKGLDPVQCKD-------------------------------------------- 
PAZ5/PTX-GFP-5'      VRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHWGC 
                     ****************                                             
 
H516L-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
H516L-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
H516L-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
H516L-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFLFPNKYFMLIQELVPVKEKNFSL 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************* * .: :   . : . * :::   
 
H516L-3'             ELSQFLLNMV-MLMGTNFSVQWRGVKVMHHTENLPFKFYFALLENLVSLVNTLSLTFRVW 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGK-LTLKF-ICTTGKLPVPWPTLVTTFAYG 
                      :  :*:::   : * :***.  *     : : *.:** :.   :*     **  **    
 
H516L-3'             SSCFCEIPRIIMKQHDFFKELPMPEGLCPEGLYFFK 
PAZ5/PTX-GFP-3'      LQCFARYPD-HMKQHDFFKS-AMPEGY--------- 

















F530S-5'             SKKWLKTWWYLFDFKPIKKKWIPKFFLCVFFFRMHKKIFFFFFYFNKINKNKIRSQAKKC 
PAZ5/PTX-GFP-5'      ------------------------------------KMHHHHHHHHDIGT---------- 
                                                         *:.....:.:.*..           
 
F530S-5'             IIIIIIIMISVPLKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLD 
PAZ5/PTX-GFP-5'      ------------MKKMIPTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLD 
                                 :*********************************************** 
 
F530S-5'             ENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLE 
PAZ5/PTX-GFP-5'      ENAEIPFLQIVTPNQMIKLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLE 
                     ************************************************************ 
 
F530S-5'             IAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIH 
PAZ5/PTX-GFP-5'      IAKNGDIQEYRDFIQVIIESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIH 
                     ************************************************************ 
 
F530S-5'             YAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDK 
PAZ5/PTX-GFP-5'      YAIMRKNKAMVSYLIDCGANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDK 
                     ************************************************************ 
 
F530S-5'             RGYNALLHAAQYNEVNSVRYLIEKGLDPVQCK---------------------------- 
PAZ5/PTX-GFP-5'      RGYNALLHAAQYNEVNSVRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGV 
                     ********************************                             
 
F530S-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
F530S-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
F530S-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
F530S-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
F530S-3'             GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPNTCHYFRVWSS 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTF----- 
                     *************************************************.    *      
 
F530S-3'             MLCEIPRSYETALFQECHARRLCTGKNYIFQRRELQTRAEVKFEGDTPCNRVKRYFRRWN 
PAZ5/PTX-GFP-3'      -----------AYGLQCFARYPDHMKQHDF------------------------------ 












Q546L-5'             KKNGFQSSSFCFLLFFQMHKRFIFFSISNKINLNKKNQIPSKMHHHHHHHHDIGTMKKMI 
PAZ5/PTX-GFP-5'      -----------------------------------------KMHHHHHHHHDIGTMKKMI 
                                                              ******************* 
 
Q546L-5'             PTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMI 
PAZ5/PTX-GFP-5'      PTQTPPRQQMMNHNHQPQQIQQPQQIQPHQPQQQQPHQFRPLDENAEIPFLQIVTPNQMI 
                     ************************************************************ 
 
Q546L-5'             KLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVI 
PAZ5/PTX-GFP-5'      KLPPMFQEQYKQLLNRWSNQCIKKSGLLYTQAVPYNQVLVLLEIAKNGDIQEYRDFIQVI 
                     ************************************************************ 
 
Q546L-5'             IESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDC 
PAZ5/PTX-GFP-5'      IESNQNKDGDENEESIQQQQQQQQLTLKSIINLIDLEGNTSIHYAIMRKNKAMVSYLIDC 
                     ************************************************************ 
 
Q546L-5'             GANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNS 
PAZ5/PTX-GFP-5'      GANLDIQNLEEGHTPLHWACIKADSSFVLQLVENGADIHLTDKRGYNALLHAAQYNEVNS 
                     ************************************************************ 
 
Q546L-5'             VRYLIEKGLDPVQCKDI------------------------------------------- 
PAZ5/PTX-GFP-5'      VRYLIEKGLDPVQCKDIQLHTAVHWTSFQGHANMARYFISLGVDPNAQDIQGRTAFHWGC 
                     *****************                                            
 
Q546L-3'             ----------------------------------------SGFIVTWDYFKSDSNAPILS 
PAZ5/PTX-GFP-3'      SCKGCFARFDHHCVWINKCIGINNQALFITVLFSYVILVISGFIVTWDYFKSDSNAPILS 
                                                             ******************** 
 
Q546L-3'             ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
PAZ5/PTX-GFP-3'      ESYIQSFLFYYTNYPFILLFSIYGIGMAIWIGKLAISQVLTILFNKTTYEQIQQIREFES 
                     ************************************************************ 
 
Q546L-3'             RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
PAZ5/PTX-GFP-3'      RQGHGHSHGGDQQCNHSHGSGGGDHGHSHGGSSGSGSGSGSGDHGHSHGGQPSLPSSSGG 
                     ************************************************************ 
 
Q546L-3'             SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
PAZ5/PTX-GFP-3'      SKKDSDKSFHNQQTNFDMYHRGVVNNVKEFLFDSQKFYFQTENIYADSRVGTSKGEELFT 
                     ************************************************************ 
 
Q546L-3'             GVVPILVELDGDVNGHKFFCQWRGRCNIRKTY-PIYLHYWKTTCSMA------NTCHYFS 
PAZ5/PTX-GFP-3'      GVVPILVELDGDVNGHKFSVSGEGEGD--ATYGKLTLKFICTTGKLPVPWPTLVTTFAYG 
                     ******************  .  *  :   **  : *::  ** .:.       * . :. 
 
Q546L-3'             RMVFNALRDTRSLKQHDFFKSAMPRRLWYRKDLYFFKDDGNYRTRCSQGSDYPLNPRRLL 
PAZ5/PTX-GFP-3'      LQCFARYPD--HMKQHDFFKSAMPEGY--------------------------------- 






Figure D.1. 1 kb DNA Ladder. An annotated figure of the 1 kb DNA Ladder from NEB (NEB, 
2020). 
 
Table D.1. Method for Staining Cellulose-Producing Stalk Cells with Calcofluor White. 
 After development on a DB plate, the fruiting bodies can be stained with calcofluor 
white to visualize cellulose, and by extension, to visualize the individual cells that make up the 
structure of the stalk assembly. A 1cm circle of agar was carefully excised from the DB plate 
containing fruiting bodies. The agar was then placed upside down on a coverslip that contained 
1 drop of calcofluor white stain (0.1% calcofluor white and 0.05% Evans blue) and 1 drop of 10% 
KOH. After 10 seconds, excess solution was aspirated, and the coverslip was examined using 
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